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Temperate phages establish lysogeny and immunity to superinfection upon phage integration. 
Brujita Integrase (Int) is a model for a recently discovered subclass of tyrosine integrases, which 
lack traditional N-terminal arm-binding domains and contain additional C-terminal degradation 
tags. Typically, the arm-binding domain recognizes binding sites in the phage attachment DNA 
(attP) and serves to control the directionality in integration and excision. The absence of this 
domain raises the question of how Brujita Int binds attachment site substrates to control site 
selectivity and directionality. In this work, we describe the DNA and protein requirements for 
Brujita Int function, how it implements site selection, directionality control, and higher order 
complex formation. We show that Brujita Int is a simple recombinase, which resembles Cre, FLP, 
and XerC/D more closely than it does the tyrosine phage integrases. In contrast to Lambda Int, 
Brujita Int uses small DNA substrates, does not discriminate between attP and attB sites, and lacks 
directional control. It also shows unusual binding to its attachment sites. Binding to attB occurs at 
two half sites, B and B’ in a cooperative manner, such that binding at B’ is required for binding at 
B. Binding to attP is also unusual. The attP site is comprised of three half sites, P, P’, and an 
additional site to the left of P, P1. However, binding is not detected at P, although this site is 
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required for recombination. Additionally, P1 is required for recombination, presumably to stabilize 
binding at P. Finally, we have solved the crystal structure of the Brujita Int and have found residues 
responsible for higher order complex formation. In total, our results indicate that Brujita Int may 
represent an evolutionary precursor to the canonical tyrosine integrases. Moreover, given its 
relative simplicity, Brujita Int presents a useful tool for the creation of synthetic genetic circuits as 





TABLE OF CONTENTS 
PREFACE ................................................................................................................................. XIII	
1.0	 INTRODUCTION ........................................................................................................ 1	
1.1	 BACTERIOPHAGES .......................................................................................... 2	
1.2	 THE GENETIC SWITCH .................................................................................. 4	
1.2.1	 Bacteriophage Lambda ................................................................................ 5	
1.2.2	 Integration-Dependent Phage Immunity .................................................... 7	
1.3	 RECOMBINATION .......................................................................................... 11	
1.3.1	 Mechanism of Tyrosine Mediated Site-Specific Recombination ............ 14	
1.3.2	 Tyrosine Recombinases .............................................................................. 15	
1.3.2.1	 FLP Recombinase ............................................................................... 15	
1.3.2.2	 Cre/loxP Recombination .................................................................... 16	
1.3.2.3	 XerC/D Recombination ...................................................................... 16	
1.3.3	 Tyrosine Integrases ..................................................................................... 18	
1.3.3.1	 Lambda Integration ............................................................................ 18	
1.3.3.2	 L5 Integration ..................................................................................... 20	
1.4	 INVESTIGATING BRUJITA INTEGRASE .................................................. 22	
2.0	 DISSECTION OF SEQUENCE REQUIREMENTS FOR BRUJITA 
RECOMBINATION ................................................................................................................... 23	
2.1	 INTRODUCTION ............................................................................................. 23	
2.2	 MATERIALS AND METHODS ...................................................................... 24	
2.2.1	 Bacterial Growth ......................................................................................... 24	
 vii 
2.2.2	 Plasmid Construction ................................................................................. 24	
2.2.3	 Integration and Stability in Mycobacteria ............................................... 27	
2.2.4	 Expression and Purification of Brujita Int ............................................... 27	
2.2.5	 In Vivo Recombination Assays ................................................................... 28	
2.2.6	 In Vitro Reaction Conditions ..................................................................... 29	
2.3	 RESULTS ........................................................................................................... 33	
2.3.1	 Analysis of Brujita Int Start Sites ............................................................. 33	
2.3.2	 Integrant Stability ....................................................................................... 34	
2.3.3	 Dissection of Brujita Int Attachment Sites ............................................... 37	
2.3.4	 Developing an In Vivo Recombination Assay ........................................... 40	
2.3.5	 Examination of attP and attB Requirements ............................................ 43	
2.3.6	 Brujita Site Selectivity ................................................................................ 47	
2.3.7	 Mapping the Brujita Crossover Positions................................................. 47	
2.3.8	 In Vitro Recombination .............................................................................. 51	
2.4	 DISCUSSION ..................................................................................................... 55	
3.0	 REQUIREMENTS FOR BRUJITA INT-DNA BINDING .................................... 58	
3.1	 INTRODUCTION ............................................................................................. 58	
3.2	 MATERIALS AND METHODS ...................................................................... 59	
3.2.1	 Annealing of Oligos ..................................................................................... 59	
3.2.2	 Electrophoretic Mobility-Shift Assays ...................................................... 59	
3.2.3	 Competition with Unradiolabeled DNA ................................................... 59	
3.2.4	 Generation of DNA Spacing Mutants ....................................................... 60	
3.2.5	 Binding Assays for Ferguson Plots ............................................................ 60	
 viii 
3.2.6	 Ferguson Plots ............................................................................................. 61	
3.3	 RESULTS ........................................................................................................... 61	
3.3.1	 Binding of Brujita Int to attB and attP DNA ............................................ 61	
3.3.2	 Competition with Unradiolabeled DNA ................................................... 63	
3.3.3	 Int-DNA Stoichiometries ............................................................................ 64	
3.3.4	 Estimating Sizes of Int-DNA Complexes .................................................. 67	
3.3.5	 Requirements for Int-attB Binding ........................................................... 70	
3.3.6	 Requirements for Int-attP Binding ............................................................ 75	
3.3.7	 Positions of attP Half-Sites and DNA Spacing .......................................... 78	
3.3.8	 Half-Site Conserved Dinucleotides ............................................................ 80	
3.4	 DISCUSSION ..................................................................................................... 83	
4.0	 STRUCTURAL COMPONENTS OF THE BRUJITA INT SYSTEM ................ 87	
4.1	 INTRODUCTION ............................................................................................. 87	
4.2	 MATERIALS AND METHODS ...................................................................... 88	
4.2.1	 Expression of Brujita Integrase ................................................................. 88	
4.2.2	 Protein Expression ...................................................................................... 88	
4.2.3	 Purification of Brujita Int .......................................................................... 88	
4.2.4	 Crystallization Conditions ......................................................................... 89	
4.2.5	 Seleno-Methionine Crystals ....................................................................... 89	
4.2.6	 Structure Solution ....................................................................................... 89	
4.2.7	 Generating Mutants .................................................................................... 90	
4.2.8	 Binding Assays ............................................................................................ 90	
4.3	 RESULTS ........................................................................................................... 91	
 ix 
4.3.1	 The Crystal Structure of Brujita Int ......................................................... 91	
4.3.2	 Domain Rotation ......................................................................................... 94	
4.3.3	 Organization of the Active Site .................................................................. 96	
4.3.4	 Designing Mutations to Analyze Protein Structure and Function ......... 99	
4.3.5	 Effects of Mutations in the Core Binding Domain ................................. 101	
4.3.6	 Effects of Mutations in the Catalytic Domain ........................................ 108	
4.4	 DISCUSSION ................................................................................................... 111	
5.0	 CONCLUSIONS AND FUTURE PERSPECTIVES ............................................ 115	
5.1	 SUMMARY OF THE BRUJITA INT SYSTEM .......................................... 115	
5.1.1	 Is Brujita Int an Integrase or Recombinase? ......................................... 116	
5.1.2	 Why is Int Promiscuous? ......................................................................... 117	
5.1.3	 Identification of Interfaces Required for Synapsis ................................ 118	
5.1.4	 What is the Role of P1? ............................................................................ 119	
5.1.5	 Int-DNA Contacts ..................................................................................... 122	
5.2	 APPLICATIONS ............................................................................................. 122	
5.3	 FUTURE DIRECTIONS ................................................................................. 123	
APPENDIX A ............................................................................................................................ 124	
APPENDIX B ............................................................................................................................ 131	
REFERENCES .......................................................................................................................... 136	
 x 
 LIST OF TABLES 
 
Table 1. Plasmids used in Chapter 2. ............................................................................................ 29	
Table 2. In vitro recombination frequencies using pBL90 ........................................................... 54	
Table 3. Plasmids used in Chapter 3. ............................................................................................ 61	
Table 4. Calculated sizes of native protein complexes ................................................................. 69	
Table 5. Plasmids used in Chapter 4. ............................................................................................ 90	
Table 6. Binding and recombination properties of Brujita Int mutants ...................................... 102	
Table 7. Infection patterns of various M. smegmatis phages. ..................................................... 129	
Table 8. Oligos for Int-DNA co-crystallization .......................................................................... 134	
 xi 
LIST OF FIGURES 
 
Figure 1: Genome map of mycobacterium phage Brujita ............................................................... 8	
Figure 2: Integration-dependent phage immunity ........................................................................... 9	
Figure 3: Diagram of integrase mediated site-specific recombination ......................................... 13	
Figure 4: Brujita Int translational start sites and stability ............................................................. 35	
Figure 5: Brujita Int is separated from its native promoter upon integration ............................... 36	
Figure 6: Brujita Int does not contain an arm-binding domain ..................................................... 38	
Figure 7: attP Mapping in M. smegmatis ...................................................................................... 38	
Figure 8: Brujita intra-molecular recombination assays ............................................................... 41	
Figure 9: Length requirements of the Brujita attachment sites ..................................................... 44	
Figure 10: Summary of Brujita attachment sites .......................................................................... 46	
Figure 11: Mutational analysis of the putative overlap region in attP and attB ........................... 49	
Figure 12: In vitro recombination using plasmid substrates ......................................................... 53	
Figure 13: Binding of Brujita Int to attP and attB DNA substrates .............................................. 62	
Figure 14: Competition experiments between hot and cold DNA ................................................ 63	
Figure 15: Hybridization assays .................................................................................................... 66	
Figure 16: Mobilities of protein standards and Int complexes ..................................................... 68	
Figure 17: Int binding to mutant derivatives of attB ..................................................................... 71	
Figure 18: Summary of Brujita Int binding to attB substrates. ..................................................... 72	
Figure 19: Summary of Brujita Int binding to attB substrates with single-base substitutions ..... 74	
Figure 20: Int binding to mutant derivatives of attP ..................................................................... 76	
 xii 
Figure 21: Summary of Brujita Int binding to mutant attP substrates .......................................... 77	
Figure 22: Mutations in the proposed bending region .................................................................. 79	
Figure 23: Brujita binding at the P half site is required for recombination .................................. 81	
Figure 24: Organization of Brujita attachment sites ..................................................................... 82	
Figure 25: A model for Brujita Int-mediated recombination ........................................................ 86	
Figure 26: Structural organization of Brujita Int .......................................................................... 92	
Figure 27: Brujita Int surface electrostatics .................................................................................. 95	
Figure 28: Rearrangement of catalytic tyrosine ............................................................................ 98	
Figure 29: Model of Brujita Int binding ..................................................................................... 100	
Figure 30: Brujita Int crystal subunit interactions ...................................................................... 101	
Figure 31: Brujita Int mutants affecting interface 2 .................................................................... 104	
Figure 32: Core binding domain mutants affect attB cooperativity ........................................... 106	
Figure 33: Mutants affect formation of interface-1 .................................................................... 107	
Figure 34: Brujita Int mutations affect catalysis ......................................................................... 109	
Figure 35: Model for Brujita Int recombination ......................................................................... 120	
Figure 36: Lysis of M. minnesotense isolates by mycobacterium phages .................................. 128	
 xiii 
PREFACE 
This work would not be possible without the support of many different people. First, I would like 
to thank my mentor, Dr. Graham Hatfull, for his guidance and direction, as well as for training me 
to become an independent scientist. I would like to thank all of the members of the Hatfull lab, 
especially those involved in the genetic switch paper, Gregory Broussard, Lauren Oldfield, Valerie 
Villanueva, and Emily Shine for their collaboration, encouragement, and advice.  
Additionally, several people were very supportive and helpful in my development as a 
scientist. I thank Ching-Chung Ko for his intellectual support, including scientific discussion 
covering nearly every aspect of my project. Shweta Singh and Gregory Broussard were great 
mentors in the early stages of my work in helping gain a perspective and grasp of my project. Bob 
Duda was also an exceptional resource to me both for technical and intellectual support. 
I especially thank the VanDemark Lab for their help with all of my protein work, both in 
technical support and training, specifically, Swarna Mohan, Adam Wier, Chris Amrich, Aubrey 
Lowen, Joel Rosenbaun, and Jenna Zalewski. I am also grateful to Dr. Andy VanDemark for his 
training in structural biology, and for his collaboration and solving of the Brujita Int crystal 
structure.  
Finally, I would like to thank my parents, Jim and Irene Lunt for their encouragement as 
well as my wonderful wife, Anna, and my sweet boys, Hyrum and Alvin, for making long hard 
days more bearable.  
Some of the work from this dissertation is from the Broussard et al., Molecular Cell 2013 
paper. Most of the in vivo work is published in Lunt and Hatfull J. Mol. Bio. 2016, and the 
structural work and protein mutants will be published in Lunt et al., in process. This work was 
 xiv 
supported by a National Science Foundation pre-doctoral fellowship 1247842 (for fellow 
2013141947). 
 1 
1.0  INTRODUCTION 
Human tuberculosis (TB) is caused by Mycobacterium tuberculosis. This disease has posed a 
global health risk in the past and currently exhibits one of the largest single risks of the present 
and future (WHO, 2016). Nearly one-third of the world’s population is infected with tuberculosis 
currently and 5% are estimated to have drug resistant infections (WHO, 2016). During 2015 alone, 
6.1 million new cases were reported and an estimated 1.4 million deaths occurred as a result of 
tuberculosis infections, making tuberculosis the leading cause of death by an infectious agent 
(WHO, 2016). At heightened risk are those with HIV infections, which escalates the probability 
of rapid TB progression soon after infection (Corbett et al., 2003). Given its prevalence, new tools 
are needed to understand, treat, and mitigate tuberculosis infections (Parisien et al., 2008).  
Bacteriophages are a powerful tool for studying mycobacteria. Mycobacteriophages, or 
phages that infect mycobacteria, are abundant and diverse, with nearly 1300 unique phages having 
been isolated and sequenced to date. These phages can be categorized by sequence similarity into 
at least 32 unique groups (http://www.phagesdb.org). Although most of these phages were isolated 
on M. smegmatis, a portion can also infect M. tuberculosis (Jacobs-Sera et al., 2012). Interestingly, 
the majority of the annotated genes in these phages have no known function (Hatfull et al., 2010, 
Casjens, 1992). Exploiting such novel genes may allow us to develop tools to manipulate, detect, 
and treat tuberculosis (Hatfull et al., 2010, Pope et al., 2015, Pope et al., 2011).  
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A novel integration-dependent switch has been found in mycobacterium phage BPs, 
Charlie, and Brujita (Broussard et al., 2013, Broussard & Hatfull, 2013). This system is much 
simpler than its counterparts in the E. coli phage Lambda and mycobacteriophage L5 systems, 
exhibiting characteristics of a streamlined and less regulated system and may represent an 
evolutionary precursor to the more complex genetic switches. Integration-dependent immunity 
consists of three components: an integrase (Int), which catalyzes site-specific recombination, 
repressor (Rep), a pro-lysogeny protein, and Cro, a pro-lysis protein. In particular, mycobacterium 
phage Brujita Int has been used as a model for studying these novel integration proteins. In Brujita, 
Int operates in novel and more simple ways when compared to traditional tyrosine integration 
systems.  
This study aims to give a comprehensive picture of mycobacterium phage Brujita 
integration system by examining the requirements for integration, binding, and complex formation. 
1.1 BACTERIOPHAGES 
Bacteriophages represent the largest single group of biomass on the planet – with 1031 in existence 
– and are predicted to be the most abundant source of novel genetic information (Hendrix, 2003, 
Wommack & Colwell, 2000, Suttle, 2005). With 1023 infections occurring every second, total 
population turnover happens every few days (Suttle, 2007, Pedulla et al., 2003). This large and 
rapidly evolving population of phages provides excellent models for studying evolution and for 
finding novel genetic systems. Indeed, much of the early work and techniques in molecular biology 
were completed and pioneered in model systems such as E. coli phage Lambda (Casjens & 
Hendrix, 2015, Abbani et al., 2007, Aihara et al., 2003, Biswas et al., 2005, Herskowitz & Hagen, 
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1980, Hsu et al., 1980, Hochschild et al., 1986). Phage Lambda was the subject of the first direct 
sequencing of biological DNA, as well as the first sequenced dsDNA virus (Wu & Kaiser, 1968, 
Onaga, 2014, Sanger et al., 1982).  
Mycobacteriophages, have proven to be exceptional tools for studying the mycobacteria. 
Their study has provided understanding of host-phage interactions, of evolution of both 
mycobacteria and the phage, and of insights into new genetic systems. These phages are used for 
manipulating genomes (Marinelli et al., 2008, van Kessel & Hatfull, 2007, Bardarov et al., 1997, 
Donnelly-Wu et al., 1993, Hatfull et al., 2010, Huff et al., 2010, Lee et al., 1991, van Kessel & 
Hatfull, 2008a, van Kessel et al., 2008, van Kessel & Hatfull, 2008b, Bardarov et al., 2002), 
transposon and reporter gene delivery systems (Bardarov et al., 2002, Bardarov et al., 2003, 
Bardarov et al., 1997), selectable markers (Donnelly-Wu et al., 1993, Petrova et al., 2015), 
integrating vectors (Huff et al., 2010, Morris et al., 2008, Lee et al., 1991, Pham et al., 2007), and 
vaccine development (Hatfull et al., 1994). Additionally, mycobacterium phages have the potential 
to be effective tools for the treatment of disease, especially tuberculosis. Work in the Hatfull 
laboratory has shown that these phages have toxin-antitoxin systems, endolysins (Payne et al., 
2009, Payne & Hatfull, 2012), lysterases, and additional toxic proteins that may prove useful for 
treatment of this disease. With the enormous amount of new genetic information still untapped 
among the nearly 1200-sequenced mycobacterium phages (http://www.phagesdb.org) there is a 
great likelihood that additional novel genes and technologies remain to be discovered and 
developed (Pope et al., 2015, Pope et al., 2011). 
The recent discovery of the integration-dependent bacteriophage immunity systems in 
mycobacteriophages represents a novel genetic switch that is much smaller and simpler than the 
canonical Lambda system and may constitute an evolutionary precursor to such systems 
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(Broussard & Hatfull, 2013).  
1.2 THE GENETIC SWITCH 
One major contribution gained from the study of phages is the discovery and characterization of 
the bistable genetic switches that determine a fate based on an external signal. The Lambda genetic 
switch controls the life cycle of the phage, determining whether productive infection proceeds 
through lysis, or whether the phage enters a dormant mode known as lysogeny (Ptashne, 2011). In 
Lambda, the switch is governed by two repressor proteins, which are negative regulators of each 
other (Ptashne et al., 1982, Dubnau & Losick, 2006, Ptashne, 2004). The Lambda genetic switch 
is quite complicated involving a variety of factors, DNA sequences, and proteins. 
When a temperate bacteriophage infects its host, the phage will proceed toward one of two 
fates, either productive infection through lysis, or establishment of a latent infection through 
lysogeny (Ptashne, 2011, Ptashne et al., 1982, Ptashne, 2004, Oppenheim et al., 2005). This 
decision between the two fates constitutes the genetic switch. If the switch is flipped toward lysis, 
the phage genome is replicated, viral proteins are made and progeny phage are packaged and 
released through lysis of the host cell. Alternatively, if the switch is flipped toward lysogeny, a 
repressor protein is expressed, which shuts down transcription of lytic genes. Additionally, a site-
specific DNA recombinase, known as an integrase (Int) is expressed. This protein catalyzes the 
recombination reaction between attachment sites in the host chromosome and the phage genome, 
resulting in an integrated phage particle, known as the prophage. The resulting cell is now a 
lysogen, in which the phage DNA is replicated with the host genome and as the bacterial cell 
divides, the phage DNA is passed to daughter cells. The repressor protein allows the prophage to 
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block expression of lytic genes, as well as prevent superinfection by other members of the same 
immunity system, thus preserving the lysogenic state (Little, 2010, Ptashne, 2011, Ptashne, 2004, 
Oppenheim et al., 2005). The lysogen is induced when a signal, such as DNA damage or cell stress, 
stimulates production of integrase and accessory proteins to exit from lysogeny. These accessory 
proteins – such as Xis – are needed to promote the excisive recombination reaction and remove 
the phage DNA from the host genome. Following excision, the phage enters lytic growth 
(Astromoff & Ptashne, 1995, Ptashne, 2011, Ptashne et al., 1982, Bloch et al., 2013). 
1.2.1 Bacteriophage Lambda 
The temperate bacteriophage Lambda has been extensively studied and its genetic switch is 
perhaps the best understood. During Lambda infection, the phage adsorbs to the exterior of the 
host cell and injects its genome, which then circularizes. RNA synthesis is initiated at two 
promoters, PR and PL, which transcribe two genes, cro and N, before transcriptional termination at 
terminators tL1 and tR1 by a protein called Rho (Casjens & Hendrix, 2015, Roberts, 1969). During 
lysis, protein N can prevent termination by binding to tR1 and allow transcription through early 
lytic genes by desensitizing RNA polymerase to Rho-dependent and Rho-independent terminators 
(Echols, 1971, Franklin, 1974, Friedman & Gottesman, 1983, Friedman & Court, 1995, Reed et 
al., 1997). One of the products made after N-mediated anti-termination is protein Q, which is also 
an anti-terminator, allowing expression of the late genes (Roberts et al., 1998). Q binds to the DNA 
at the transcription complex and migrates with this complex as it transcribes the late genes, which 
leads to lysis of the host cell (Deighan & Hochschild, 2007, Shankar et al., 2007, Marr et al., 
2001). 
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The Lambda lysogeny switch consists of two major players, the pro-lysis protein Cro, and 
repressor (CI), which promotes lysogeny (Hochschild et al., 1986). Cro and cI are separated by 3 
operator DNA sequences, OR1, OR2, and OR3, with each protein having different affinities for 
each site (Cro prefers OR3, CI prefers OR1 and OR2) (Campbell, 1994). The repressor binds weakly 
– but cooperatively – in dimers to OR1 and OR2, blocking the ability of RNA polymerase to bind 
and transcribe cro. At the same time it recruits polymerase to transcribe its own gene (Ptashne, 
2011). At high concentrations of CI, binding will occur at OR3, which loops the DNA using 
protein-protein interactions between the other occupied OR sites, preventing RNA polymerase 
from transcribing repressor (Lewis et al., 2011, Cui et al., 2013a, Cui et al., 2013b, Priest et al., 
2014). Thus, Lambda repressor is able to both positively and negatively regulate its own 
expression in response to protein levels (Campbell, 1994, Reichardt & Kaiser, 1971). In a similar 
manner, Cro binds to OR3 and blocks expression of CI. At high concentrations, Cro also binds to 
OR2 and OR1, preventing its own transcription (Campbell, 1994).  
Among the genes transcribed with the help of anti-terminator N, are cII and cIII, which 
encode two accessory factors that play important roles in the switch. CII is a transcription factor 
that is required for initial expression of CI at the promoter PRE, yet CII is rapidly degraded in E. 
coli; Because of this, CIII is required to prevent degradation and stabilize CII (Ptashne, 2004, 
Campbell, 1994, Halder et al., 2007, Kobiler et al., 2002, Shotland et al., 2000). Though CI and 
Cro are the central players, CII levels determine whether the phage will enter lytic growth or 
lysogeny (Kobiler et al., 2002). When host protease levels are low, CII will accumulate, lead to 
expression of cI, and establishment of lysogeny. Following UV treatment or when proteases are 
abundant, CII will be rapidly degraded, cI will not be expressed, and lytic growth will follow 
(Lederberg & Lederberg, 1953, Court et al., 2007). 
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Although there are occasional differences, the Lambda genetic switch is quite typical of 
many temperate phage switches (Campbell, 1994, Knight et al., 1989). In such lambdoid genetic 
switches, production of integrase occurs after the lysogeny decision has been made and CI has 
repressed lytic gene expression. In this case, integration contributes to stability of the lysogen, but 
has no role in the decision to enter lysogeny. 
1.2.2 Integration-Dependent Phage Immunity 
In contrast to the lambdoid phages, we have recently discovered a much simpler genetic switch in 
the mycobacteriophages, where integrase is the key player in this decision. Integration-dependent 
phage immunity is a novel type of genetic switch that consists of only three genes: int (Int), rep 
(Rep), and a predicted cro (Figures 1-2) (Broussard et al., 2013). There are no analogs for the 









Figure 1: Genome map of mycobacterium phage Brujita 
Mycobacteriophage Brujita genome map is shown with a ruler denoting genome length. Boxes 
above the ruler represent genes transcribed in a rightward direction and those below are transcribed 












Figure 2: Integration-dependent phage immunity 
A. The lysogenic genetic switch of Mycobacterium phage Brujita consists of three genes, int, rep, 
and a putative cro. The attP core is located within the repressor gene, such that, upon integration, 
(B) the 3’ end of the gene is truncated and a shorter functional form of the repressor is made. 
 
Integration-dependent immunity has been studied using mycobacteriophages Brujita, 
Charlie, and BPs. Genes int and rep are transcribed in the leftward direction and a putative cro is 
transcribed rightward (Figure 2). Rep and cro are separated by 155 bp, a region that contains the 
operator sites and two promoters, PRep and PR (Broussard & Hatfull, 2013, Villanueva et al., 2015). 
PRep drives expression of rep and int, while PR drives expression of cro.  The operator, OR is a 12 
base pair sequence, which can be bound by Rep to block expression of cro (Villanueva et al., 
2015).  
In contrast to phage Lambda, integration-dependent immunity is largely regulated through 
protein stability as both Int and Rep contain DNA encoded proteolytic degradation tags with 
limited similarity to the ssrA tag found in M. smegmatis (Broussard et al., 2013). These tags cause 
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degradation when attached to GFP in vivo and are likely used to maintain a rapid turnover of both 
Int and Rep (Broussard et al., 2013). Since Int is the determining factor in this system, the 
degradation tag allows Int to be controlled at the host-protease level, where low protease levels 
would favor Int accumulation, followed by integration (Broussard & Hatfull, 2013). This provides 
an elegant feedback system, comparable to CII-degradation in E. coli (see section 1.2.1).  
As in the Lambda system, Brujita integration occurs between attB and attP. attB is found 
in the bacterial chromosome located in a tRNAThr. Though they integrate at different attB sites, 
other tyrosine integrase systems also use tRNA-associated attB sequences (Campbell, 1992, 
Dupont et al., 1995, Gabriel et al., 1995, Hauser & Scocca, 1992b, Hayashi et al., 1993, Inouye et 
al., 1991, Kolot & Yagil, 1994, Papp et al., 1993, Pierson & Kahn, 1987, Reiter et al., 1989, Smith-
Mungo et al., 1994). Because the host cannot readily alter its tRNA without losing functionality, 
this presumably is advantageous; thus, the insertion site is maintained over long evolutionary 
history. Additionally, many of these integrases recombine near the anticodon loop of the tRNA, 
likely because the built-in dyad symmetry of the anticodon loops provides appropriate spacing for 
both binding and recombination (Hauser & Scocca, 1992a).  
The second insertion site is attP, which in Brujita-like systems, is found near the 3’ end of 
rep (Figure 2). Upon integration between attP and attB, rep is disrupted and a premature stop 
codon is introduced, which removes the C-terminal degradation tag. This allows for the expression 
of a stable and active truncated version of the repressor (Broussard & Hatfull, 2013, Broussard et 
al., 2013). This tag has been shown to not only cause repressor turnover, but also prevent the 
normal function of repressor (Broussard et al., 2013). The full-length form of repressor cannot 
accumulate to bind OR in vivo (though it can bind these sequences in vitro (Villanueva et al., 2015)) 
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and does not accumulate to high enough levels to provide superinfection immunity against phages 
in the same repressor group. 
The putative Brujita Cro currently lacks a known function (Broussard et al., 2013). Cro has 
not been successfully deleted and is assumed to be required for the lytic cycle (Broussard & 
Hatfull, 2013). Although Cro does reduce lysogenization frequencies when expressed from a 
plasmid, it does not repress the PRep promoter (Broussard & Hatfull, 2013, Broussard et al., 2013). 
It is possible in this system that the putative Cro function is mis-annotated, as it does not appear to 
have any similarity to repressor or other Cro proteins, but does have limited similarity to Xis and 
other DNA binding proteins.  
1.3 RECOMBINATION 
The family of tyrosine recombinases is broad and includes the integrases and simple recombinases, 
such as Cre, FLP, and XerC/D. Brujita Int is a member of the tyrosine integrase family, though it 
exhibits many characteristics of the tyrosine recombinases. In order to understand how Brujita Int 
fits within the context of the family of tyrosine recombinases, this section will detail the 
characteristics of the well-known recombinases as well as those of canonical integrases.  
The lysogenic genetic switch discussed above depends on the function of an integrase 
protein for lysogen stability. Integrases are members of the larger family of site-specific DNA 
recombinases, which come in two flavors – the serine and tyrosine recombinases – categorized 
based on the catalytic residue that attacks the DNA backbone. Serine integrases are characterized 
by relatively large and diverse two-domain proteins (500-900 residues), small attB and attP sites 
(<50bp) (Ghosh et al., 2003, Bibb et al., 2005), and recombination by staggered double-stranded 
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DNA breaks creating two-base 3’ overhangs (Ghosh et al., 2003). Serine integrases also do not 
require any accessory proteins, but do require recombination directionality factors (RDFs). For 
example, Bxb1-Int and φC31-Int require an RDF for excision, but instead of performing this role 
by DNA binding, the RDFs function by binding to Int, using protein-protein interactions to 
modulate Int activity (Ghosh et al., 2006, Khaleel et al., 2011). In the phage integrases described 
to date, both serine and tyrosine, all require an Xis for excision (Khaleel et al., 2011). 
More than 1300 tyrosine recombinases have been identified (Van Houdt et al., 2012). They 
form two groups: the phage integrases (Lambda Int, L5 Int, P22 Int, HK022 Int), and the simple 
recombinases (XerC/D, Cre, FLP) (Groth & Calos, 2004b). Both groups share several features. 
They require a region of identity located near the positions of cleavage and strand exchange, known 
as the core. Both classes also share a basic two-domain structure consisting of a core-DNA binding 
domain and a catalytic domain. Though there is little DNA or amino-acid similarity between any 
two integrases or recombinases, these proteins perform their respective functions using the same 
reaction mechanism (Chen et al., 1992, Hoess & Abremski, 1985, Gronostajski & Sadowski, 1985, 
Evans et al., 1990, Pargellis et al., 1988). This mechanism consists of a pairwise exchange of 
single DNA strands on opposing duplexes followed by ligation and formation of a Holliday 
junction intermediate. A second set of cleavages and strand exchange occurs, and the intermediate 
is resolved into the recombination product. Although sequences differ greatly between the 
members of the integrase and recombinase families, several conserved residues are found, which 
make up the active site tetrad (RHRY) (Chen et al., 1992, Groth & Calos, 2004b).  
There are many differences between the recombinases and integrases. The recombinases 
are bidirectional and exhibit no directionality control, a major difference from the integrases (Van 
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Duyne, 2015, Midonet & Barre, 2014, Jayaram et al., 2015). They also do not require cofactors 
such as IHF or Fis.  
In contrast, the tyrosine integrases use two non-identical DNA sites for recombination 
(Figure 3). In addition, they contain an N-terminal arm-binding domain. This combination – 
required for arm-type binding of DNA and control of directionality – is a characteristic shared by 
nearly all of the previously discovered tyrosine integrase proteins (Groth & Calos, 2004b). 
Additionally, all discovered integrases, both tyrosine and serine, require an RDF (such as Xis) for 
excision (Khaleel et al., 2011). Tyrosine recombinases can use two identical sites for 
recombination and as such, have no recombination directionality control (Groth & Calos, 2004b, 
Radman-Livaja et al., 2006). 
 
 
Figure 3: Diagram of integrase mediated site-specific recombination 
Tyrosine integrases, such as Lambda Int perform site specific recombination between two sites, 
attP and attB (top). The reaction requires four subunits of Int to bind the core DNA sites (B, B’, 
P, and P’) as well as the arm-type sites (P-arm and P’-arm) to form synapsis. A cofactor, IHF is 
also required for the reaction. Integration produces attL and attR products (bottom), consisting of 
a different arrangement of the core and arm-sites. The excision reaction is a reverse of integration, 
requiring an additional protein, Xis to reform attP and attB.  
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1.3.1 Mechanism of Tyrosine Mediated Site-Specific Recombination 
Though they have largely different sequence and cofactor requirements, all of the tyrosine site-
specific recombinases use the same reaction mechanism (Grindley et al., 2006, Groth & Calos, 
2004b). Recombination depends upon a conserved active-site tetrad, RHRY. As the tyrosine 
recombinases do not use metal cofactors, the RHRY tetrad instead provides the positively charged 
residues to activate the scissile phosphodiester bond (Grindley et al., 2006). Mutation of any one 
of these residues prevents cleavage of DNA (Chen et al., 1992). 
In tyrosine-mediated recombination, the hydroxyl group of the catalytic tyrosine (from the 
RHRY tetrad) acts as the nucleophile for strand cleavage (Chen et al., 1992). This results in a 
transesterification and a 3’ phosphotyrosyl bond between the recombinase and DNA, and a free 5’ 
hydroxyl group on the cleaved DNA strand (Cao et al., 1997). Subsequently, this 5’ hydroxyl 
group now acts as a nucleophile in a second cleavage step and attacks the phosphotyrosyl bond of 
the opposite DNA duplex. This results in cleavage of the protein-DNA bond and formation of 
recombinant DNA with four interlinked DNA strands in a Holliday junction intermediate (Kitts & 
Nash, 1987, Arciszewska et al., 1995, West, 1997, West, 1996). From this point, the reaction can 
proceed in one of two directions. The second cleavage step can occur using the same two subunits, 
resulting in regeneration of original substrate DNAs. Alternatively, the complex can proceed 
through branch migration where the DNA-protein complexes shift to activate the second pair of 
proteins, causing a separating and ligation of the spacer DNA. In the tyrosine recombinases, the 
spacer is 6-8 base pairs, which must be identical between the two DNA duplexes for migration to 
occur (Furth et al., 1983, Groth & Calos, 2004b, Rajeev et al., 2009). Once branch migration has 
finished, the second pair of proteins now attacks the phosphate backbone to form the 
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phosphotyrosine bond. This bond is once again broken by attack of the free hydroxyl group, 
resulting in the recombinant DNA product (Grindley et al., 2006). 
1.3.2 Tyrosine Recombinases 
Several tyrosine recombinases have been studied in detail. Of particular importance are FLP, Cre, 
and XerC/D. This class of proteins perform varied functions in a variety of hosts including 
chromosome maintenance of replicons and plasmid copy number control. In all cases, these 
recombinases and integrases require a spacer region of 6-8 bp, which is identical in both DNA 
sites. This spacer is placed between the cleavage points, and the requirement for spacer identity 
between attachment sites is due to branch migration, which is inhibited by any mismatches in the 
spacer region (Furth et al., 1983, Nunes-Duby et al., 1989, Nunes-Duby et al., 1987, Kitts & Nash, 
1987, Richet et al., 1988, Nash & Robertson, 1989, Rajeev et al., 2009). 
1.3.2.1 FLP Recombinase 
FLP recombinase is encoded by the 2 µm plasmid of Saccharomyces cerevisiae. It 
facilitates an increase in copy number of the plasmid during replication to allow daughter cells to 
maintain the plasmid during cell division (Chen et al., 2000, Sadowski, 1995, Senecoff et al., 
1985). FLP inverts sequences between two 599 bp repeats, of which, fewer than 65-bp are required 
for inversion (Broach et al., 1982). The FLP recombination site contains three 13-bp repeats, the 
second and third of which are inverted relative to each other and are separated by an 8-bp spacer 
(Senecoff et al., 1985, Qian & Cox, 1995). The first repeat is positioned directly next to the second, 
in the same orientation, and is not required for recombination activity (Andrews et al., 1985). The 
minimal sequence required for in vitro recombination is 28-bp, including two 10-bp inverted 
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repeats and the 8-bp spacer (Senecoff et al., 1985). There is also some flexibility with the length 
of the spacer region, as FLP can recombine using 7 or 9-bp spacer (Senecoff et al., 1985). 
The FLP synaptic complex contains four monomers. Recombination in trans, such that the 
catalytic tyrosine of one protein is shared with its partner and cleaves the DNA bound by the 
partner protein (Chen et al., 1992, Lee et al., 1996). FLP mediates recombination without 
additional proteins or accessory factors (Cox, 1983). 
1.3.2.2 Cre/loxP Recombination 
The Cre/loxP system is found in E. coli bacteriophage P1 and functions to circularize P1 
DNA during host infection (Sternberg et al., 1981, Segev & Cohen, 1981). It also resolves 
concatenates that form during genome replication in the lysogen for efficient segregation (Austin 
et al., 1981, Sternberg et al., 1981). 
Cre recombines between two identical 34 bp loxP sites that consist of two 13 bp inverted 
repeats separated by 8 bp (Hoess et al., 1982). Cre cleavage creates 6 bp 5’ DNA overhangs 
(Shaikh & Sadowski, 1997). Cre binds cooperatively to loxP sites (Hoess & Abremski, 1984), 
cleaves DNA in a trans-mechanism (Shaikh & Sadowski, 1997), and requires no additional 
proteins for recombination (Hamilton & Abremski, 1984, Abremski et al., 1986, Abremski & 
Hoess, 1985). 
1.3.2.3 XerC/D Recombination 
The E. coli XerC/D system converts multimers of ColE1 based plasmids, arising by 
homologous recombination, to monomers. This leads to stable segregation and inheritance of the 
plasmids (Summers & Sherratt, 1984, Blakely et al., 1991). It also aids in chromosome segregation 
during cell division by a similar mechanism (Blakely et al., 1991). XerC/D like systems are widely 
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found in bacteria (Arciszewska & Sherratt, 1995), with BLAST results showing hundreds of 
potential homologs. This unusual recombination system requires two closely related recombinases, 
XerC and XerD, which function in tandem (Blakely et al., 1993, Colloms et al., 1990).  
Recombination products differ depending on whether the substrate is a plasmid or the 
bacterial chromosome (Blakely et al., 1991, Blakely et al., 1993, Kuempel et al., 1991). 
Recombination at cer, the ColE1 plasmid site, is exclusively intramolecular and requires accessory 
proteins, ArgR and PepA, as well as 190-bp of accessory DNA adjacent to the 30-bp core (Blakely 
et al., 1993, Stirling et al., 1988, Stirling et al., 1989, Summers & Sherratt, 1988, Colloms et al., 
1990). These accessory factors and sequences are required for maintaining the intramolecular 
recombination preference (Blakely et al., 1993). In contrast, recombination at the dif recognition 
sequence in the bacterial chromosome occurs both inter-molecularly and intra-molecularly, 
requiring only XerC, XerD, and 28-bp of DNA (Blakely et al., 1991, Blakely et al., 1993). The 
core site consists of 11-bp XerC and XerD binding sites separated by a 6-8 bp spacer (6 bp for dif 
and 8bp for cer) (Sherratt et al., 1995). These binding sites have partial dyad symmetry (Hayes & 
Sherratt, 1997). 
XerC/D bind cooperatively to core sites (Colloms et al., 1990, Blakely et al., 1993). 
Recombination proceeds with top strand exchange, mediated by XerC and occurs in cis (Blakely 
et al., 1993, Arciszewska & Sherratt, 1995). XerD then mediates cleavage and strand exchange of 
the bottom strand. Dif core sequences have a 6-bp spacer region, though recombination can occur 
at reduced rates with an 8-bp spacer, as is found in the cer site (Blake et al., 1997). 
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1.3.3 Tyrosine Integrases 
1.3.3.1 Lambda Integration 
Tyrosine integrases differ from tyrosine recombinases in that they contain an additional N-
terminal arm-type binding domain, which is used to control directionality of recombination. Their 
attB sequences are similar to recombinase binding sites (~24 bp). However, integrases require 
large attP sites (~240 bp in Lambda) (Mizuuchi & Mizuuchi, 1980). 
Lambda Int is perhaps the best understood tyrosine integrase and is prototypical of the 
other tyrosine integrase systems. This 3-domain protein recombines an attachment sites in the 
bacterial chromosome with a site in the phage genome (attB and attP, respectively). During 
Lambda lysogeny, CII activates the PI promoter, which transcribes int, but not xis (Casjens & 
Hendrix, 2015). The int mRNA from the PL promoter contains a sib site, which leads to its 
degradation, causing Int to accumulate only in the presence of high levels of CII-activated PI 
transcription, ensuring that the phage is committed to lysogeny (Schindler & Echols, 1981, 
Gottesman et al., 1982). If Int is present in large enough concentration, it will facilitate 
recombination of the phage genome into the host chromosome, leading to a stable prophage 
existence. 
Upon DNA stress caused by UV light, mitomycin C, or other factors, the prophage induces 
expression of int and xis and undergoes excision and induction of lytic expression (Casjens & 
Hendrix, 2015, Oppenheim et al., 2005). The mRNA control ceases after integration, and moderate 
levels of Int and Xis are sufficient to cause excision (Gottesman et al., 1982, Schindler & Echols, 
1981).  
Although the Lambda attB sequence is 24 bp, the attP site requires 240 base pairs of DNA 
(Mizuuchi & Mizuuchi, 1980). attP contains binding sites for IHF (H1, H2, and H3), Xis (X1 and 
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X2) (Craig & Nash, 1984, Gardner & Nash, 1986), and arm-type interactions (P1, P2, P’1, P’2, 
P’3) (Hsu et al., 1980, Ross & Landy, 1983). Both attP and attB share a region of identity, known 
as the core (C and C’).  
Lambda Int contains three domains: The N-terminal arm-type binding domain (NTD), the 
core DNA binding domain, and the C-terminal catalytic domain (CTD). The NTD binds with high 
affinity to the attP arm-sites, which flank the core by 40-120 bp. Subsequently, the core DNA sites 
C and C’ are recognized by the core-binding domain (Seah et al., 2014, Gottfried et al., 2000). 
Lambda Int simultaneously binds to both arm-sites and the core-sites, which requires severe DNA 
bending facilitated by IHF for integrative recombination (Seah et al., 2014, Kim & Landy, 1992, 
Miller et al., 1979). The Int-attP complexes then capture attB DNA, forming a synaptic complex 
and allowing recombination to occur. Lambda can cleave DNA using a cis-mechanism, meaning 
that the catalytic tyrosine attacks DNA that is bound by the same subunit (Nunes-Duby et al., 
1994). However, some data suggests a trans-mechanism – or nucleophilic attack of DNA bound 
by a neighboring subunit – can occur (Han et al., 1993). It is possible that Lambda is capable of 
both methods of cleavage and may prefer one or the other depending on the environment. 
The Lambda Int C-terminal tail has a novel function in that it stabilizes the nucleophilic 
tyrosine of the neighboring Int subunit in trans (Landy, 2015). This region (approximately 30 
residues) appears to reposition between the monomeric form and the tetrameric Int bound to 
Holliday junction (HJ) DNA (Kwon et al., 1997, Aihara et al., 2003). This region includes the 
catalytic tyrosine (Y342), which repositions 26 Å between the two structures. Additionally, the 
extreme C-terminus (including strand β-7) extends from one promoter of Int to the active site of 
another, forming a trans-interaction that may coordinate activity of the subunits during synapsis 
and recombination (Landy, 2015).  
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The Recombination Directionality Factor (RDF), also known as Xis, is a DNA binding and 
bending protein (Yin et al., 1985, Sam et al., 2004, Abremski & Gottesman, 1982, Kim & Landy, 
1992). Xis alters the macromolecular architecture of the complex, partnering with previously used 
IHF, Int, and attL and attR DNA to allow the formation of the excisive synaptic complex. Xis is 
not only required for excisive intasome formation, but also heavily inhibits the formation of 
integrative complexes by binding to X1 and X2 on attP DNA (Moitoso de Vargas et al., 1989, 
Ross & Landy, 1983, Richet et al., 1988). Therefore, the presence or absence of Xis controls the 
directionality of the recombination reaction. Fis is a host-encoded factor that stimulates inversions 
(Seah et al., 2014). It can also aid excisive recombination under low Xis concentrations by binding 
to its site, which corresponds to the Xis binding site, X2 (Numrych et al., 1991, Ball & Johnson, 
1991, Thompson et al., 1987b) 
1.3.3.2 L5 Integration 
Another well-studied, canonical tyrosine integrase is L5 Int. Mycobacterium phage L5 is a 
temperate phage that infects M. smegmatis, as does phage Brujita. However, the L5 genetic switch 
is similar to that of Lambda, but lacks CII and CIII. It is not known if L5 has anti-termination, but 
it does have some terminators (Brown et al., 1997, Donnelly-Wu et al., 1993). There are 
approximately 30 asymmetric repressor binding sites throughout the L5 genome, known as 
stoperators, to which the repressor binds in order to cumulatively shut down gene expression (Pope 
et al., 2011, Brown et al., 1997). Even with these differences, the general scheme for integration 
and excision are similar to those of Lambda (Lewis & Hatfull, 2003, Pena et al., 2000, Pena et al., 
1997b, Azaro & Landy, 2002). 
The L5 integration system has a 43-bp core sequence that is found in all four DNA sites 
(attB, attP, attL, and attR), and overlaps a host tRNAGly gene (Lee et al., 1991, Pena et al., 1996). 
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Upon integration, the attP core sequence replaces part of the tRNA gene, preserving the integrity 
of the tRNA, which is required for M. smegmatis growth (Pena et al., 1997b). Only 29-bp of the 
attB core sequence are required for recombination (Pena et al., 1996). L5 attP is a 240 bp sequence, 
which contains binding sites for Int-arm interactions (P1-P7), Int-core interactions, mIHF binding, 
and Xis binding. Although L5 attP has seven arm-sites, only four of them are needed for 
integration (P1, P2, P4, and P5) (Pena et al., 1997b). mIHF is required for recombination, but does 
not bind DNA independent of Int. mIHF is also thought to make protein-protein contacts with Int 
(Lewis & Hatfull, 2003, Pena et al., 1999, Pena et al., 2000) 
Like Lambda Int, L5 Int is a three-domain protein containing N-terminal arm binding 
(NTD), core binding, and C-terminal catalytic domains (CTD). L5 uses a different host factor, 
mIHF to facilitate DNA bending and the site locations and orientations differ from that of Lambda 
(Pena et al., 1997b, Pedulla et al., 1996). Also like Lambda, L5 forms higher order intasome 
complexes with IHF binding on both sides of the core (Pedulla et al., 1996, Pena et al., 1999, 
Richet et al., 1986, Thompson et al., 1987a). However, L5 only uses the right arm sites, P4 and 
P5, to form this complex. The left sites, P1 and P2 are bound by Int, which can then capture attB 
DNA (Pena et al., 2000, Pena et al., 1999, Lewis & Hatfull, 2003). 
L5 Int cleavage generates 7 bp 5’ extensions, similarly to Lambda (Pena et al., 1996). Like 
the other tyrosine integrases, it requires an RDF, or Xis protein, for excision and directionality 
control (Lee & Hatfull, 1993, Pedulla et al., 1996). Unlike the Lambda system, L5 Xis does not 
interact with Int, but functions by DNA bending alone (Lewis & Hatfull, 2003). Additionally, 
supercoiling of either attB or attP in vitro increases the frequency of the reaction, but is not 
required (Pena et al., 1998).   
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1.4 INVESTIGATING BRUJITA INTEGRASE 
Brujita Int is a model for a new subclass of tyrosine integrases that deviate from the canonical 
systems (such as Lambda Int and L5 Int). Members of this new subclass do not contain N-terminal 
arm binding domains and do not appear to use these interactions to control recombination 
directionality. Additionally, Brujita Int appears to be more similar to the tyrosine recombinases. 
How then does Brujita Int control directionality? How does it function and what are its DNA and 
protein requirements? 
The following chapters will address these questions using in vivo and in vitro 
recombination assays to investigate the DNA and protein requirements for recombination. DNA 
binding assays will be used to identify binding sites, important nucleotides, and cleavage points. 
Finally, X-ray crystallography combined with analysis of specific protein mutants will help 
identify requirements for synapsis and complex formation.  
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2.0  DISSECTION OF SEQUENCE REQUIREMENTS FOR BRUJITA 
RECOMBINATION 
Work discussed in this chapter was published in the following articles: 
 Broussard, G.W., Oldfield, L.M., Villanueva, V.M., Lunt, B.L., Shine, E.E., 
Hatfull, G.F., January 2013. Integration-Dependent Bacteriophage Immunity Provides Insights 
into the Evolution of Genetic Switches. Molecular Cell, Volume 49, Issue 2, Pages 237-248. 
 Lunt, B.L., and Hatfull, G.F., January 2016. Brujita Integrase: A Simple, Arm-
Less, Directionless, and Promiscuous Tyrosine Integrase System. J Mol Biol, Volume 428, Issue 
11, Pages 2289-2306. 
Figures 4, 6, and 7 are adapted from Broussard et al., 2013. Figures 8, 9, and 10 are adapted 
from Lunt and Hatfull, 2016. The experiments discussed below were performed by the author 
unless otherwise stated. Emily Shine performed the experiments testing PInt for activity. Many of 
the figures and tables were made in collaboration with Gregory Broussard and Graham Hatfull. 
2.1 INTRODUCTION  
Broussard et al. showed that Brujita Int contains no arm-type binding domain and most likely does 
not contain the cognate arm-binding DNA sites (Broussard et al., 2013). Without the arm-type 
binding domain, the questions arise of whether Brujita Int has an alternative mechanism for arm-
type interactions, whether it controls directionality of recombination, and whether it forms a 
similar synaptic complex to the prototypical Lambda integration system. Interactions between the 
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arm-binding domain and DNA arm sites are used by canonical tyrosine integrases to control 
recombination directionality (Van Duyne, 2005). Additionally, Lambda Int requires arm-type 
interactions for integration as Lambda Int without this domain can nick DNA, but lacks 
recombination activity (Landy, 2015, Tirumalai et al., 1997). 
Toward this end, I will first characterize the Brujita DNA site requirements. This chapter 
discusses the DNA and cofactor requirements of Brujita Int. 
2.2 MATERIALS AND METHODS 
2.2.1 Bacterial Growth 
M. smegmatis cultures were grown in 7H9 broth or 7H10 agar (Difco) with carbenicillin (50 
µg/ml), cyclohexamide (10 µg/ml), and appropriate antibiotics. E. coli cultures were grown in LB 
broth or agar (Difco) with appropriate antibiotics. 
2.2.2 Plasmid Construction 
Plasmid pBL03 was created by site-directed mutagenesis, which deleted the attP core (Brujita 
29,173-29,211) from pGWB87. Plasmid BL04 was created by site-directed mutagenesis, changing 
TGG to TAG by making the mutation in pGWB87 synonymous with Brujita C28935T. Plasmid 
BL05 was created by site-directed mutagenesis, changing TTG to TAG by making the mutation 
synonymous with Brujita A28980T in pGWB87. Plasmid BL06 was created by cloning the PCR 
amplified fragment Brujita 28,970-29,411 into the Hind III and Nhe I sites of pYUB854 (Bardarov 
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et al., 2002). Plasmid BL08 was created by cloning the PCR amplified fragment Brujita 28,970-
29,311 into the Hind III and Nhe I sites of pYUB854. Plasmid BL10 was created by cloning the 
PCR amplified fragment Brujita 28,970-29,231 into the Hind III and Nhe I sites of pYUB854. 
Plasmid BL14 was created by cloning the PCR amplified fragment Brujita 28,970- 29,211 into the 
Hind III and Nhe I sites of pYUB854. Plasmid BL26 was created by cloning the PCR amplified 
fragment Brujita 28,970-29,206 into the Hind III and Nhe I sites of pYUB854. 
Plasmid BL15 was created by cloning the PCR amplified fragment Brujita 29,073-29,411 
into the Hind III and Nhe I sites of pYUB854. Plasmid BL23 was created by cloning the PCR 
amplified fragment Brujita 29,138-29,411 into the Hind III and Nhe I sites of pYUB854. Plasmid 
BL24 was created by cloning the PCR amplified fragment Brujita 29,143-29,411 into the Hind III 
and Nhe I sites of pYUB854. Plasmid BL39 was created by cloning the PCR amplified fragment 
Brujita 29,138-29,211 into the Hind III and Nhe I sites of pYUB854. Plasmid BL40 was created, 
using site-directed mutagenesis and changing ATG to ATC by making the mutation synonymous 
with Brujita C28946G in pGWB87. Plasmid BL41 was created, using site-directed mutagenesis 
and changing the TTG to CTC by making the mutations synonymous with Brujita C28979G and 
A28981G in pGWB87. Plasmid BL42 was created, using site-directed mutagenesis and changing 
the ATG to ATC by making the mutation synonymous with Brujita C29009G in pGWB87. 
Plasmid pBL61 expressing IntLong was constructed as follows: plasmid pET21a was 
digested with Nde I and Hind III and a 957 bp IntLong fragment corresponding to Brujita coordinates 
29011 - 28057 was PCR amplified and joined to pET21 using Gibson Assembly (Invitrogen). 
Plasmid pBL60 expressing IntShort was constructed similarly using a 894 bp PCR fragment 
containing Brujita coordinates 28948 – 28057. Plasmid pBL51 expressing an MBP-Int fusion was 
constructed by linearizing plasmid pLC3 (Owens et al., 2006) with Nde I and Hind III and ligating 
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it with the 957 bp IntLong PCR product. Plasmid pBL83 was made by digestion of pBAD28, which 
contains an arabinose inducible promoter, (Guzman et al., 1995) with Kpn I and Xba I and ligating 
it with a PCR amplified fragment consisting of Brujita IntLong cleaved with Kpn I and Xba I. All 
Int expressing plasmids contain a stabilizing mutation (A296E).  
Plasmids containing attP and attB were created from a pJL37 backbone (Bibb & Hatfull, 
2002). The hsp60 promoter was removed by digestion with Xba I and Nde I and replaced with a 
999 bp hygromycin resistance marker, PCR amplified from pYUB854 (Bardarov et al., 2002). 
attP constructs of differing lengths (shown in Figure 9), were PCR amplified and inserted into the 
Bam HI and Nde I sites, and attB constructs were similarly inserted into the Not I and Kpn I sites 
using either Infusion (Clontech) or Gibson Assembly (Invitrogen). All plasmid constructs were 
verified by Sanger sequencing. Counter-selection plasmids (pBL90 derivatives) were modified 
from pBL50-derived plasmids by digestion with Dra I and cloning of a PCR amplified ccdB gene 
and upstream sequence (including the promoter region, 669 bp total) from pDONR/Zeo (Thermo 
Fisher Scientific). All ccdB plasmids were grown in One Shot ccdB survival competent cells 
(Thermo Fisher Scientific). 
Attachment site mutants were generated using Quick Change Site-Directed Mutagenesis 
(Stratagene) to generate mutants shown in Figure 10. Mutants were PCR amplified and cloned into 
the pBL90 backbone as described above. Mutants were recombined using integrase expressing 
pBL83 cells as before. Following recombination, plasmid was extracted from transformed colonies 
and sequenced to determine the presence of the mutation. Start site mutants (Figure 4) were 
generated using Site-Directed Mutagenesis with pGWB87 as a template.  
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2.2.3 Integration and Stability in Mycobacteria 
The Brujita attP requirements for integration were determined by co-transformation of M. 
smegmatis mc2155 with attP-containing plasmids and int-expressing plasmid pBL03. Plasmid 
stability was determined by growing M. smegmatis containing pBL06 (containing 442bp attP), 
pGWB81 (an integrative plasmid containing rep and WT, unstable int), and pGWB87 (an 
integrative plasmid containing rep and stabilized int) (Broussard et al., 2013) to saturation with 
selection, diluting 1:10,000 into selection-free media, and growing to saturation twice, for a total 
of approximately 26 generations. Cultures were plates for individual colonies and were tested for 
drug resistance.  
2.2.4 Expression and Purification of Brujita Int 
Plasmid pBL61, which places IntLong under the E. coli lac promoter, was transformed into BL21-
CodonPlus (DE3)-RIPL cells (Agilent). An isolated colony was used to inoculate 50 ml of LB and 
antibiotics and incubated overnight at 37°C. After incubation, the cells were pelleted and used to 
inoculate 2 liters of autoinduction media (Studier, 2005). The cells were incubated with shaking 
for 18 hours at room temperature, pelleted, and frozen at -80° C. Thawed pellets were resuspended 
in 10 ml/gram lysis buffer (10 mM phosphate pH 7.0, 400 mM NaCl, 5 mM BME, 5 mM 
imidazole, 5% glycerol), protease inhibitors added (PMSF, leupeptin, aprotinin, and pepstatin) and 
lysed by three passes through a homogenizer. The lysed cells were spun at 30,000 x g in a Sorvall 
Lynx 6000 centrifuge for 40 minutes at 4° C. Untagged Int was isolated using nickel affinity 
chromatography as native integrase has been found to bind well to nickel, followed by heparin 
affinity chromatography. Integrase containing fractions were further purified by size exclusion 
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chromatography, dialyzed into freezer storage buffer, (10 mM Phosphate pH 7.0, 400 nM NaCl, 
50% glycerol, 5 mM BME) and stored at -20° C. 
2.2.5 In Vivo Recombination Assays 
To assay for integrase-mediated recombination in M. smegmatis, 50 ng of an int-expressing 
plasmid pBL03 (Broussard et al., 2013) and 50 ng plasmid pLB50 were co-electroporated into M. 
smegmatis mc2155 and transformants were recovered on solid media containing kanamycin. 
Colonies were then picked onto plates containing either kanamycin or kanamycin and hygromycin. 
Recombination frequency was recorded as the percentage of transformants isolated on kanamycin 
related to those selected with both antibiotics.  
For E. coli recombination assays, plasmid pBL83 was transformed into Stellar competent 
cells (Clontech), an isolated colony selected, and grown in LB broth with antibiotics overnight to 
saturation. Three ml of overnight culture were inoculated into 100 ml fresh broth with antibiotics 
and grown at 37° C with vigorous shaking to O.D.600 = 0.5. Forty-five minutes after inoculation, 
arabinose was added to final concentration of 40 mM to induce Int expression. Cells were pelleted 
and washed 4 times with 10% ice-cold glycerol, frozen on dry ice, and stored at -80° C until use. 
Un-induced control cells were made similarly without the addition of arabinose. Recombination 
was measured by electroporating 50 ng of substrate plasmid DNA containing directly oriented 
attachment sites into Stellar E. coli cells carrying pBL83 and selecting kanamycin resistant 
transformants. Recombination frequencies were determined as cfu/µg DNA. Error values represent 
the average efficiency ± one standard error of the mean value for three separate transformations 
(six for the experiment shown in Fig. 9). 
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2.2.6 In Vitro Reaction Conditions 
In vitro reactions were performed in XerD reaction buffer (Colloms et al., 1996), containing 50 
mM Tris, pH 8.0, 50 nM NaCl, 1.25 mM EDTA, 5 mM spermidine, 1 mM L-arginine, 25 µg/ml 
BSA, and 10% glycerol. Approximately 100 ng DNA and dilutions of Int ranging from 0 to 625 
nM (final concentration) were added and the reactions were incubated at 37°C for 2 hours. 
Following incubation, half of the reaction was linearized by adding 1 ul NEB Buffer 2.1 and 0.5 
µl NotI to each sample, incubating for 2 hours at 37°C. Each sample was then added to 1 µl 
10mg/ml Proteinase K and 1 µl 10% SDS and incubated at 65°C for 20 minutes. Linearized and 
non-linearized samples were run on 0.6% agarose TBE gels overnight at 20V and stained with 
ethidium bromide. 
 




pBL03 pGWB87 with SDM attP core (39bp) deletion Broussard et al., 2013 
pBL04 pGWB87 with SDM TGG-TAG (downstream of 
third start site)  
Broussard et al., 2013 
pBL05 pGWB87 with SDM TTG-TAG (second start site) Broussard et al., 2013 
pBL06 pYUB854 with 442 bp attP (203L, 239R) cloned 
into Hind III and NheI sites  
Broussard et al., 2013 
pBL08 pYUB854 with 342 bp attP (203L, 139R) cloned 
into Hind III and NheI sites 
Broussard et al., 2013 
pBL10 pYUB854 with 262 bp attP (203L, 59R) cloned into 
Hind III and NheI sites 
Broussard et al., 2013 
pBL14 pYUB854 with 242 bp attP (203L, 39R) cloned into 
Hind III and NheI sites 
Broussard et al., 2013 
pBL15 pYUB854 with 339 bp attP (100L, 239R) cloned 
into Hind III and NheI sites 
Broussard et al., 2013 
pBL23 pYUB854 with 274 bp attP (35L, 239R) cloned into 
Hind III and NheI sites 
Broussard et al., 2013 
pBL24 pYUB854 with 269 bp attP (30L, 239R) cloned into 
Hind III and NheI sites 
Broussard et al., 2013 
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pBL26 pYUB854 with 237 bp attP (203L, 34R) cloned into 
Hind III and NheI sites 
Broussard et al., 2013 
pBL39 pYUB854 with 74 bp attP (35L, 39R) cloned into 
Hind III and NheI sites 
Broussard et al., 2013 
pBL40 pGWB87 with SDM ATG-ATC (third start site) Broussard et al., 2013 
pBL41 pGWB87 with SDM TTG-CTC (second start site) Broussard et al., 2013 
pBL42 pGWB87 with SDM ATG-ATC (first start site) Broussard et al., 2013 
pBL45 pGWB87 with SDM ATG-ATC (third start site) and 
TTG-CTC (second start site)  
This study 
pBL46 pGWB87 with SDM ATG-ATC (third start site) and 
ATG-ATC (first start site) 
This study 
pBL47 pGWB87 with SDM TTG-CTC (second start site) 
and ATG-ATC (first start site) 
This study 
pBL50 pJL37 with Hsp60 replaced with HygR (from 
pYUB854) cloned into XbaI and NdeI sites, attB436 
cloned into KpnI and NotI sites, and attP442 cloned 
into BamHI and NdeI sites 
Lunt and Hatfull, 2016 
pBL51 pLC3 with Brujita IntLong cloned into NdeI and 
HindIII sites 
Lunt and Hatfull, 2016 
pBL61 pet21a with Brujita IntLong cloned into NdeI and 
HindIII sites. Stop codons were introduced before 
His tag 
Lunt and Hatfull, 2016 
pBL83 pBAD28 with Brujita Int cloned into KpnI and XbaI 
sites 
Lunt and Hatfull, 2016 
pBL90 pBL50 with ccdB (from pDONRZeo) cloned into 
DraI site 
Lunt and Hatfull, 2016 
pBL103 pBL90 with 242 bp attP (203L, 39R) Lunt and Hatfull, 2016 
pBL105 pBL90 with 274 bp attP (35L, 239R) Lunt and Hatfull, 2016 
pBL106 pBL90 with 269 bp attP (30L, 239R) Lunt and Hatfull, 2016 
pBL111 pBL90 with 270 bp attB (35L, 235R) Lunt and Hatfull, 2016 
pBL116 pBL90 with 240 bp attB (201L, 39R) Lunt and Hatfull, 2016 
pBL118 pBL90 with 284 bp attP (45L, 239R) Lunt and Hatfull, 2016 
pBL120 pBL90 with 232 bp attP (203L, 29R) Lunt and Hatfull, 2016 
pBL144 pBL90 with attL440 and attR438 replacing attB and 
attP 
Lunt and Hatfull, 2016 
pBL145 pBL90 with 217 bp attP (203L, 14R) Lunt and Hatfull, 2016 
pBL146 pBL90 with 212 bp attP (203L, 9R) Lunt and Hatfull, 2016 
pBL147 pBL90 with 215 bp attB (201L, 14R) Lunt and Hatfull, 2016 
pBL148 pBL90 with 210 bp attB (201L, 9R) Lunt and Hatfull, 2016 
pBL149 pBL90 with 250 bp attB (15L, 235R) Lunt and Hatfull, 2016 
pBL150 pBL90 with 245 bp attB (10L, 235R) Lunt and Hatfull, 2016 
pBL151 pBL90 with 205 bp attB (201L, 4R) Lunt and Hatfull, 2016 
pBL152 pBL90 with SDM changing position 1 of the attB 
core T-A 
Lunt and Hatfull, 2016 
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pBL153 pBL90 with SDM changing position 2 of the attB 
core A-T 
Lunt and Hatfull, 2016 
pBL154 pBL90 with SDM changing position 3 of the attB 
core A-T 
Lunt and Hatfull, 2016 
pBL155 pBL90 with SDM changing position 4 of the attB 
core T-A 
Lunt and Hatfull, 2016 
pBL156 pBL90 with SDM changing position 5 of the attB 
core G-C 
Lunt and Hatfull, 2016 
pBL157 pBL90 with SDM changing position 6 of the attB 
core A-T 
Lunt and Hatfull, 2016 
pBL158 pBL90 with SDM changing position 7 of the attB 
core A-T 
Lunt and Hatfull, 2016 
pBL159 pBL90 with SDM changing position 8 of the attB 
core T-A 
Lunt and Hatfull, 2016 
pBL160 pBL90 with SDM changing position 9 of the attB 
core A-T 
Lunt and Hatfull, 2016 
pBL161 pBL90 with SDM changing position 1 of the attP 
core T-A 
Lunt and Hatfull, 2016 
pBL162 pBL90 with SDM changing position 2 of the attP 
core A-T 
Lunt and Hatfull, 2016 
pBL163 pBL90 with SDM changing position 3 of the attP 
core A-T 
Lunt and Hatfull, 2016 
pBL164 pBL90 with SDM changing position 4 of the attP 
core T-A 
Lunt and Hatfull, 2016 
pBL165 pBL90 with SDM changing position 5 of the attP 
core G-C 
Lunt and Hatfull, 2016 
pBL166 pBL90 with SDM changing position 6 of the attP 
core A-T 
Lunt and Hatfull, 2016 
pBL167 pBL90 with SDM changing position 7 of the attP 
core A-T 
Lunt and Hatfull, 2016 
pBL168 pBL90 with SDM changing position 8 of the attP 
core T-A 
Lunt and Hatfull, 2016 
pBL169 pBL90 with SDM changing position 9 of the attP 
core A-T 
Lunt and Hatfull, 2016 
pBL171 pBL90 with 14 bp attB (5L, 9R) Lunt and Hatfull, 2016 
pBL173 pBL90 with 49 bp attP (35L, 14R) Lunt and Hatfull, 2016 
pBL177 pBL144 with 240 bp attL (201L, 39R) Lunt and Hatfull, 2016 
pBL178 pBL144 with 215 bp attL (201L, 14R) Lunt and Hatfull, 2016 
pBL179 pBL144 with 210 bp attL (201L, 9R) Lunt and Hatfull, 2016 
pBL180 pBL144 with 274 bp attL (35L, 239R) Lunt and Hatfull, 2016 
pBL181 pBL144 with 249 bp attL (10L, 239R) Lunt and Hatfull, 2016 
pBL182 pBL144 with 244 bp attL (5L, 239R) Lunt and Hatfull, 2016 
pBL184 pBL144 with 19 bp attL (5L, 14R) Lunt and Hatfull, 2016 
pBL186 pBL144 with 242 bp attR (203L, 39R) Lunt and Hatfull, 2016 
pBL187 pBL144 with 212 bp attR (203L, 9R) Lunt and Hatfull, 2016 
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pBL188 pBL144 with 207 bp attR (203L, 4R) Lunt and Hatfull, 2016 
pBL189 pBL144 with 335 bp attR (100L, 235R) Lunt and Hatfull, 2016 
pBL190 pBL144 with 270 bp attR (35L, 235R) Lunt and Hatfull, 2016 
pBL191 pBL144 with 260 bp attR (30L, 235R) Lunt and Hatfull, 2016 
pBL192 pBL144 with 44 bp attR (35L, 9R) Lunt and Hatfull, 2016 
pBL200 pBL144 with 217 bp attR (203L, 14R) Lunt and Hatfull, 2016 
pBL202 pBL144 with 250 bp attR (25L, 235R) Lunt and Hatfull, 2016 
pBL204 pBL90 with 240 bp attB (5L, 235R) Lunt and Hatfull, 2016 
pBL205 pBL90 with 235 bp attB (0L, 235R) Lunt and Hatfull, 2016 
pBL206 pBL144 with 205 bp attL (201L, 4R) Lunt and Hatfull, 2016 
pBL207 pBL144 with 239 bp attL (0L, 239R) Lunt and Hatfull, 2016 
pBL208 pBL90 with 264 bp attP (25L, 239R) Lunt and Hatfull, 2016 
pBL213 pBL90 with SDM changing position 1 of the attP 
and attB cores T-A 
Lunt and Hatfull, 2016 
pBL214 pBL90 with SDM changing position 2 of the attP 
and attB cores A-T 
Lunt and Hatfull, 2016 
pBL215 pBL90 with SDM changing position 3 of the attP 
and attB cores A-T 
Lunt and Hatfull, 2016 
pBL216 pBL90 with SDM changing position 4 of the attP 
and attB cores T-A 
Lunt and Hatfull, 2016 
pBL217 pBL90 with SDM changing position 5 of the attP 
and attB cores G-C 
Lunt and Hatfull, 2016 
pBL218 pBL90 with SDM changing position 6 of the attP 
and attB cores A-T 
Lunt and Hatfull, 2016 
pBL219 pBL90 with SDM changing position 7 of the attP 
and attB cores A-T 
Lunt and Hatfull, 2016 
pBL220 pBL90 with SDM changing position 8 of the attP 
and attB cores T-A 
Lunt and Hatfull, 2016 
pBL221 pBL90 with SDM changing position 9 of the attP 
and attB cores A-T 
Lunt and Hatfull, 2016 
pBL222 pBL144 with 24 bp attL (5L, 19R) Lunt and Hatfull, 2016 
pBL223 pBL144 with 49 bp attR (35L, 14R) Lunt and Hatfull, 2016 
pBL224 pBL90 with attB436 replacing attP (attB in both 
locations) 
Lunt and Hatfull, 2016 
pBL225 pBL90 with attP442 replacing attB (attP in both 
locations) 
Lunt and Hatfull, 2016 
pBL226 pBL224 with attB74 (35L, 39R) in both sites Lunt and Hatfull, 2016 
pBL227 pBL224 with attB74 (35L, 39R) in the KpnI and 
NotI sites, and attB19 (5L, 14R) in the BamHI and 
NdeI sites 
Lunt and Hatfull, 2016 




2.3.1 Analysis of Brujita Int Start Sites 
The Brujita Int coding sequence contains three different translation start sites within the first 22 
codons and it is not clear from bioinformatic data which of these is used in vivo. To determine 
which start site is correct, synonymous or conservative site-directed mutants were made in each 
translation start codon within an integrating plasmid, to test their impact upon Int activity (Figure 
4). Integrating plasmids were created to express integrase protein and attP, so that when introduced 
to the host containing an attB, the plasmid will integrate into the attB site. The integrating plasmid 
contains a selection marker and does not contain a mycobacterial origin of replication, so that 
selection of this marker eliminates non-integrating events. Plasmids containing these mutants were 
transformed into M. smegmatis and selected for integration ability. 
There is little difference in integration efficiency compared to wild type when mutating the 
second or third start sites (TTG and ATG, mutants 4 and 3, respectively), suggesting that these 
mutations do little to alter the activity of Int (Figure 4). Mutant 2 creates a stop codon downstream 
of all three start sites, and results in no integration, showing that the translational start occurs before 
this sequence. Additionally, altering the TTG to a TAG stop codon (mutant 1, Figure 4) reduces 
recombination 100-fold, suggesting that the main start codon occurs at or before this site. However, 
mutant 1 yields active protein in vivo, though perhaps not as efficient as the full-length version, 
implying that some translation initiates after this codon. Mutation of the first ATG start reduces 
integration efficiency 10-fold, which we interpret to mean that this is the primary site used in vivo. 
Interestingly, this is not responsible for the entirety of translation initiation, as there is still Int 
functionality without this site (Figure 4).  
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In combination, our results show that translation begins with the first ATG start, as it yields 
the most active protein. Moreover, mutating both of the other two start codons (pBL45, mutants 
3,4) results in efficient recombination. Additionally, every combination of mutants that includes 
allele 5 results in poor integration efficiency. The fact that start positions 2 and 3 yield some 
activity is likely due to lower levels of translation initiation at these sites or that a less effective Int 
protein produced. 
2.3.2 Integrant Stability 
One unique feature of the integration-dependent phage immunity systems is the integrase C-
terminal degradation tag (Broussard et al., 2013). In Brujita, this tag can be eliminated by mutation 
of the penultimate alanine to glutamic acid A317E (A296E in early nomenclature due to a mis-
annotation). Stabilizing Int by mutating this tag increases integration efficiency nearly 800-fold by 
stabilizing the protein (Broussard et al., 2013). 
Broussard et al., hypothesized that this degradation tag may have some effect on the ability 
to form lysogens. However, phages containing this mutation decrease the numbers of lysogens 
formed and instead create clear plaques (Broussard et al., 2013). This effect could result from 
either poor integration or increased excision. To further clarify, we compared the excision ability 
of both wild type and the stabilized mutant Int allele (Figure 4). Although the stabilizing Int allele 
increases integration activity, it also causes unstable integrants (compare excision frequencies of 
pGWB81 and pGWB87, Figure 4), suggesting that activity of the protein is controlled by Int 
accumulation, instead of DNA topology, as in Lambda (Landy, 2015). 
Brujita integration is likely controlled by Int accumulation through constant turnover of the 
protein, using the C-terminal degradation tag (Broussard et al., 2013). Upon integration, Int is 
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separated from its native promoter, PRep, and placed under the control of some unknown promoter, 
which would be required for expression of Int in a lysogen (Broussard et al., 2013). One potential 
source of Int transcription in the lysogen is a predicted promoter in the 5’ region of the Int coding 
sequence (PInt), the resulting mRNA would contain translation start 3, the most downstream site, 
but not start site 1. To examine the effect of each of these starts on excision, the mutants described 
above were also tested for integrant stability (Figure 4).  
 
 
Figure 4: Brujita Int translational start sites and stability 
Brujita Int contains three potential translational start-sites. A variety of mutations were made to 
test the effect of each site on integration (transformation efficiency) and integrant stability 
(excision). Mutant alleles are shown in red below the wild type nucleotide, with the corresponding 
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mutant number. A predicted promoter, PInt, is positioned with the -35 box overlapping the first 
start site and the -10 box overlapping a single base of the second start site. 
 
Integrated test plasmids containing unstable wild type Int are preserved in every colony 
tested over 26 generations of unselected growth. In contrast, analogous experiments using the 
stabilizing mutation leads to only 27% retention of the integrative plasmid over the same time 
frame. It appears that the action of removing this degradation tag stimulates excision, suggesting 
that this process (like integration) is also controlled by Int concentration. This control may be due 
to promoter activation or by a decrease in degradation levels, allowing Int accumulation to lead to 
excision. However, as noted above, the full-length version of Int (IntLong) cannot be expressed from 
the predicted promoter PInt (Figure 5). Instead, the only translational product would be IntShort, 
translated from the most 3’ ATG start site (Figure 4). This version of Int is capable of integration, 
but at much lower levels than IntLong.  
 
 
Figure 5: Brujita Int is separated from its native promoter upon integration 
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The Brujita genetic switch is organized with the attP site in the 3’ region of rep. Upon integration 
by Int, rep is cleaved, producing a truncated, active form of the repressor. After integration, PRep 
is separated from Int, and further expression of Int must come from either predicted promoter PInt, 
or a nearby PBac. 
 
 
Mutations in Brujita Int translational start sites show intriguing differences in integration 
and excision frequencies. Int with mutations in the second or third start site (mutants 4 and 3, 
pBL41 and pBL40 respectively) only slightly alter recombination and result in stable integrants. 
Additionally, pBL45 – which contains a competent version of IntLong – is incapable of causing 
excision, implying that something other than Int length is important for this process. Indeed, a 
portion of the -10 box of the predicted PInt overlaps mutant 4, which may be sufficient to disable 
this promoter in vivo (Figure 4). Unfortunately, attempts to show activity of this promoter in vivo 
have not been successful (Emily Shine, personal communication), so the validity of this sequence 
as a promoter is unclear.  
2.3.3 Dissection of Brujita Int Attachment Sites 
Brujita Int exhibits an unusual integrase that lacks an N-terminal arm-type binding domain 
common to the other tyrosine integrases, and thus, Brujita may not utilize corresponding arm-type 
DNA sites that are normally present in attP. To determine the minimal attP sequences needed for 
in vivo recombination, deletion analyses were performed using a two-part integrative plasmid 
system. A plasmid expressing A317E stabilized Int was co-transformed into M. smegmatis cells 
along with plasmid containing various sized attP sequences. The mixture of these plasmids allows 
Int to be produced and integrate the second plasmid into the host attB. However, since Int 
containing plasmid cannot replicate, and the integrating (attP containing) plasmid lacks Int, it 
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cannot be excised in future generations. The transformants were selected using a kanamycin 
resistance marker on the integrating plasmid. 
 
 
Figure 6: Brujita Int does not contain an arm-binding domain 
Schematic of the domains of Lambda Int compared to Brujita Int. Brujita Int does not contain an 
arm-binding domain, but has an additional C-terminal degradation tag not found in Lambda Int. 
The Brujita Int start site is ambiguous, as there are three potential starts in the first 22 codons. See 




Figure 7: attP Mapping in M. smegmatis 
Brujita attP was tested for the minimal DNA requirements by transforming integrating plasmids 
containing different sized attP segments into M. smegmatis. The number of transformants were 
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counted and expressed as a percent of control. Brujita genome coordinates are given as boundaries 
of tested fragments. 
 
 
The core region is a segment of identity between attP and attB. The Brujita attB site is 
located in an essential tRNAThr (Broussard et al., 2013). Using a normal attP, this integration 
results in a complete tRNAThr with the attP core becoming the 3’ half of a functional tRNAThr, due 
to identity of the core sequences. This identity of the core region is not only required for the 
recombination mechanism, but additionally is potentially needed to preserve the function of the 
tRNA upon integration.  
 Lambda integration requires a 240 bp attP (Landy & Ross, 1977, Radman-Livaja et al., 
2006). We used the integration assay described above to determine the sequence required for 
Brujita integration. Truncation of the attP sequence from the left side (P) shows little difference 
in integration until approximately 35 bp left of the core. When this region is removed, 
transformation efficiencies are decreased 10-fold, suggesting that this sequence is important for 
integration (Figure 7). Similarly, truncation from the right-side results in little or no loss of 
transformation affinity until the core region is truncated, a finding that is not surprising, due to its 
presumed role in replacing a portion of the tRNA upon integration. However, in Brujita, the core 
is 39 bp, and it is likely that this entire sequence is not required for recombination – but instead 
for the maintenance of tRNA activity – as the core requirement in other tyrosine recombinases is 
limited to 6-8 bp (Landy, 2015). From this data, we conclude that the Brujita attP site is much 
smaller than in the classical tyrosine integrase systems, such as Lambda, (240 bp) (Landy & Ross, 
1977, Radman-Livaja et al., 2006), whereas this data shows that Brujita functions with 74 base 
pairs and thus lacks arm-type DNA binding domains (Broussard et al., 2013).  
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2.3.4 Developing an In Vivo Recombination Assay 
The Brujita attP and the M. smegmatis attB share 39 bases of identity, known as the core sequence. 
As attB occurs in this tRNA, a portion of the 74-base pair attP requirement is likely needed to 
preserve this tRNA following integration. Moreover, the actual biochemical requirements of this 
site may be much smaller, as is the case in the L5 Int system (Pena et al., 1997a). To test this 
hypothesis, we developed a plasmid integration system, lacking this tRNA, where both attP and 
attB flank a hygromycin resistance marker (see Figure 8A for reference). The construct under 
discussion lacks ccdB, such that upon recombination, the marker is lost. Using this system, we can 
test attP constructs smaller than the 74 bases previously found, as well as attB fragments, both of 





Figure 8: Brujita intra-molecular recombination assays 
Plasmids used for recombination assays in vivo. Plasmids pLB90 (A), pBL144 (B), pBL224 (C), 
and pBL225 (D), each contain an E. coli replication origin (oriE), a mycobacterial origin of 
replication (oriM), kanamycin and hygromycin resistance genes, and the counter-selectable ccdB 
gene (Bernard et al., 1994, Hiraga et al., 1986). Plasmid pBL90 contains Brujita attP and attB sites 
in direct orientation such that recombination between them yields two products, one containing 
the origins of replication and kanamycin resistance and the other carrying hygromycin resistance 
and ccdB; plasmids pBL144 (attL × attR), pBL224 (attB × attB) and pBL225 (attP × attP) are 





To validate this assay, we first verified its function in M. smegmatis by co-transforming 
the plasmid pBL50 (containing attP-HygR-attB) along with a plasmid expressing a stabilized 
Brujita integrase mutant, pBL03. Transformants were screened for loss of hygromycin resistance 
and compared to control levels. We found that recombination occurs in approximately 41% of 
colonies tested, and that recombination frequencies of truncated attP showed similar trends to 
those found previously (Broussard et al., 2013).  
As we sought to understand whether any cofactors were required, we needed to examine 
these requirements outside of the context of the mycobacteria. To accomplish this, we first had to 
verify that the system functions in E. coli. We proceeded using a pBAD derived plasmid (pBL83) 
to express A317E stabilized integrase. These cells were additionally transformed with the pBL50 
derived plasmids of interest, and sensitivities of the transformed colonies were determined. Both 
the M. smegmatis and E. coli data agree with previous results (data not shown), demonstrating that 
this plasmid system is a valid substitute for chromosomal integration assays.  
While both of these approaches are helpful for validation of the intra-molecular 
recombination assay, it became clear that a simpler and more efficient system was needed, as the 
above screens were unable to easily distinguish between good and poor recombination efficiencies. 
To solve this problem, we developed a counter-selection plasmid by inserting a ccdB gene – which 
is toxic when expressed in a non-permissive strain (Hiraga et al., 1986) – into the region between 
attP and attB sites (Figure 8A). This construction allows for selection of recombined plasmids, as 
a failure to recombine results in cell death. The plasmid of interest was then transformed into cells 
expressing Brujita Int and the numbers of transformed colonies were recorded and expressed as 
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recombination efficiency (cfu/µg transformed DNA).  
2.3.5 Examination of attP and attB Requirements 
We used our intra-molecular recombination system to probe the DNA sequence requirements of 
attP. We examined progressively smaller attP fragments and found that the right side of the attP 
core (bases 14 through 39 of the core) is not needed for integrative recombination (see Figure 9A). 
When we remove the 5 bases from positions +9 to +14 in the core, a distinct drop in efficiency is 
observed (~100 fold), suggesting that this region is required for efficient recombination. Similarly, 
when the region left of the core is truncated, the region from positions -35 to -30 shows a ~50-fold 
drop in efficiency, also indicating that this region is important for integrative recombination. A 
fragment consisting of the region from -35 to +14 yields recombination levels similar to wild type, 
demonstrating that this region is both necessary and sufficient for recombination in vivo. 
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Figure 9: Length requirements of the Brujita attachment sites 
Length requirements for attP (A), attB (B), attL (C), and attR (D). Plasmid pBL90 contains 442 
bp attP DNA (phage coordinates 28,970 to 29,411) and a 436-bp attB site with the common cores 
centrally located. When transformed into E. coli cells expressing Brujita Int (pBL90 +) and ccdB 
is counter-selected, approximately 8 × 104 colonies per microgram (cfu/μg) DNA are recovered; 
 45 
recombination is Int-dependent and few colonies are recovered in the absence of Int (pBL90 −). 
Plasmid derivatives of pBL90 were constructed in which segments of either attP or attB (A and 
B, respectively) were deleted from the left or right ends, as indicated by the deletion endpoint 
coordinates, and the numbers of recombinants recovered reported as a percent of control (shown 
at right). Derivatives of pBL144 (see Figure 8) were similarly tested for attL (C) and attR (D) 
length requirements. E. Int-mediated recombination of pBL224 (attB × attB) and pBL225 (attP × 
attP) and derivatives. Errors values represent the standard errors of three separate transformations. 
 
Using the intra-molecular recombination assay, the sequence requirements of attB were 
similarly examined (Figure 8B). When the region from +4 to +9 is removed, recombination is 
eliminated (10,000-fold decrease, Figure 9B). When the region from -5 to 0 is removed, efficiency 
similarly drops ~100-fold. Surprisingly, when the fragment from -5 to +9 is tested, efficiency is 
lower than when either individual side is tested, implying that, though not required, the exterior 
plasmid sequences may be contributing to sequence recognition. 
Since the attP site is comprised of P and P’ half sites and the attB of B and B’ half sites 
(Figure 9A-B) (Ross et al., 1979), we expected that when testing the requirements for attL and 
attR, we would see a combination of the individual sequence requirements (attL being the 
composite of B and P’ and attR being the composite of P and B’). However, this was not entirely 
the case. The attR half site P was similar to the attP requirement (a 10-fold drop from -35 to -30, 
Figure 9A, D), but the B’ half site fragments contained in pBL187 (+9 segment) was 10-fold lower 
than the control, even though in attB this fragment was sufficient for recombination (Figure 9B, 
D).  
The B half site of attL shows similar results to those found earlier (see Figure 9B-C), with 
~100-fold decrease in efficiency after deleting the region -5 to 0, suggesting this region is 
necessary in both attB and attL. In the P’ prime half-site of attL, deleting +9 to +14 does not 
change the efficiency of recombination, even though this deletion shows a 100-fold change in attP 
(Figures 9A, C). Also of interest is the minimal attL sequence (pBL184 fragment). Even though 
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the regions of -5 and +14 are both necessary, the fragment -5 to +14 is not sufficient for excisive 
recombination, suggesting that additional sequence may be needed for this reaction. Additionally, 
this assay is performed in a plasmid background, which may be contributing required sequences, 
making it difficult to identify precise boundaries. Regardless of these restrictions, it is clear that 
the Brujita attachment sites differ from those of the other tyrosine recombinases. It contains a small 
~24 bp attB sequence, similar to the Lambda system, and a small, asymmetrical 49 bp attP 
sequence, much smaller than traditional systems, which require ~240 bp for proper arm-type 
interactions (Mizuuchi & Mizuuchi, 1985, Mizuuchi & Mizuuchi, 1980). The observation that 
sequence requirements for integration and excision are similar, if not the same (attP is the same as 
attR and attB is the same as attL), suggests that there is no means of directionality control and no 
recombination directionality factor (RDF) in the Brujita system, a feature that is characteristic of 
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attP and attB share a 39-bp common core sequence (boxed) that overlaps a host tRNAThr gene. Int-
mediated strand exchange occurs within the common core to form attL and attR product sites. 
Because the recombination requirements do not extend beyond the common core to its right, the 
B′ and P′ sites are identical, and thus, attP and attR as well as attB and attL are functionally 
equivalent. The regions required for in vivo recombination are highlighted in red.  
 
2.3.6 Brujita Site Selectivity 
Because Brujita Int does not use arm-type interactions and there appear to be difference in the 
requirements between integrative and excisive recombination substrates, we sought to understand 
whether Int differentiates between attP and attB sequences. Plasmids containing either attP x attP 
or attB x attB (pBL225 and pBL224, respectively, Figure 8C-D, 9E) were constructed as before 
and tested for recombination ability. Surprisingly, both plasmids are competent for recombination, 
although at slightly lower levels than with attP x attB substrates. Plasmids containing smaller attB 
sequences also recombine, but this does not proceed with attB sequences are smaller than ~74 bp 
(pBL226, pBL227, and pBL228, Figure 9E). These results were verified to be Int-dependent, and 
not a result of homologous recombination. The ability of Int to recombine identical sites, as well 
as normal attB x attP recombination is unexpected. This suggests that Int is promiscuous and has 
little (if any) preference between DNA sites. This is especially surprising, considering that attP 
and attB have different boundaries and sequences.  
2.3.7 Mapping the Brujita Crossover Positions 
In Lambda, Int binds to attP and attB sites separated by a 7-base spacer between cleavage points 
(Grindley et al., 2006, Groth & Calos, 2004a). Cre also exhibits similar binding using a 6-base 
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spacer (Van Duyne, 2001). In both cases, recombination results in cleavage at the 5’ end of the 
spacer, creating overhangs that then participate in strand exchange (Van Duyne, 2001, Grindley et 
al., 2006). Since the attachment sites are much smaller in the Brujita Int system than in Lambda, 
we questioned whether the positions of Int binding and strand exchange would also be different. 
To test this, we designed several mutations in the attP core of an integrating M. smegmatis plasmid. 
However, because this core replaces the 3’ half of a functional tRNAThr in M. smegmatis, only a 
few specific positions would give interpretable data, while producing a functional tRNA and 
allowing the integrant to survive. Mutations were made separately in the 3rd, 6th, and 9th bases of 
the core (A-T, A-G, and A-C respectively) and selected for integration of the plasmid. Successful 
integrants were recovered and sequenced in the attL and attR regions to identify the location of the 
mutant base. In all cases tested, the A-T mutation in the third position of the core segregated to 
attR (n=4) and the other two mutations segregated to attL (n=4, n=3), suggesting that strand 
exchange occurs between positions three and six of the attP core (data not shown).  
Due to the limitations of performing this experiment in M. smegmatis, the plasmid-based 
counter selectable intra-molecular recombination system was adapted to use attP or attB with each 
of the first nine bases individually mutated (Figure 10). Integrative recombinants were selected, 
recorded, and the recovered colonies were sequenced as before to identify the final location of the 
mutated bases. Because this system results in the loss of ccdB and the attR containing DNA, 
mutants can only be recovered if they segregate to the attL site. Mutations in positions 1, 2, and 9 
of the core reduce recombination approximately 100-fold and mutations in positions 3, 4, and 5 
show ~10 fold reduction in recombination when mutated. Positions 6-8 show a slight change in 




Figure 11: Mutational analysis of the putative overlap region in attP and attB 
(A) Derivatives of plasmid pBL90 were constructed with single-base substitutions between 
coordinates + 1 and + 9 in attP, attB, or both attP and attB as indicated, and tested for 
recombination. Positions of the base substitutions are shown, together with the numbers of 
recombinant products in which the substitution is present in the attL product. (B) Diagram of attP 
and attB sequences showing positions of cleavage (arrows). Minimal sequences required for in 
































































































































In the Lambda system, mutating nucleotides near the positions of strand exchange can be 
very informative. If a base is located in a binding site, the mutation will interfere with 
recombination and lower its efficiency (Campbell, 1992, Rajeev et al., 2009). A similar result will 
occur of the mutation is located in the crossover, or spacer region. However, when compensating 
mutations are made in the corresponding attachment site, it becomes clear whether the mutated 
base is located in a binding site or the spacer. If the position is in the spacer, the compensating 
mutation will restore the recombination defect, while no such change will occur for a position 
involved in binding (Furth et al., 1983, Rajeev et al., 2009).  
With this in mind, we made compensating mutations in the attP core and tested 
recombination efficiencies (Figure 11, pBL213-221). Positions 1 and 9 are not restored by the 
compensating mutation, suggesting that these positions are involved in binding to Brujita Int. 
When the compensating mutation is made in positions 2 and 3, recombination is largely restored, 
implying that these are located in the spacer region. However, no other locations exhibit similar 
behaviors to this position, which is unexpected. Also unexpected is the behavior of position 5 
(pBL156 and pBL217). When one attachment site contains the mutation, recombination is 
decreased by ~10 fold. However, the compensating mutation causes a 100-fold decrease in 
recombination, which implies that this position has some sort of binding role and that mutation 
here has an additive effect. Unfortunately, these data do not present a clear picture of what is 
occurring in these positions. Further work will need to be done in order to clarify these questions.  
We recovered and sequenced transformants from each of the above mutants to track the 
final location of mutations in each position (Figure 11). We found that mutations in attB positions 
7, 8, and 9 are never found in attL and are likely to segregate to attR, meaning that they are to the 
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right of the cleavage point. Mutants in positions 1-6 are found at intermediate frequencies in attL, 
suggesting that these are between cleavage positions. Sequence data from attP agrees, with the 
sole exception of position 1, in which no mutants are found in attL. However, very few 
transformants could be recovered from parents with one mutant in this position, so it is likely that 
this is due to small sample size. These data are consistent with a model in which the positions of 
cleavage are to the left of core position 1 and to the right of core position 6, which would create 6-
base overhangs (Figure 11).  
2.3.8 In Vitro Recombination 
In the tyrosine recombinase family of proteins, much has been learned about recombination 
mechanisms, cleavage positions, and cis- versus trans-cleavage using in vitro recombination 
assays, as they allow a careful dissection of the requirements and features of the system 
(Arciszewska et al., 1995, Arciszewska & Sherratt, 1995, Lee & Hatfull, 1993, Nash, 1975, Ghosh 
et al., 2007, Gibb et al., 2010). One goal in exploring the Brujita system was to develop a similar 
assay for Brujita Int.  
To identify conditions likely to facilitate in vitro recombination, we began experimenting 
with various conditions used for Lambda Int, XerC/D, and L5 Int in vitro recombination 
(Arciszewska et al., 1995, Arciszewska & Sherratt, 1995, Colloms et al., 1996, Lee & Hatfull, 
1993, Nash, 1975, Syvanen, 1974). Using these various buffer conditions, we tested whether Int, 
attP, and attB were sufficient to cause recombination in vitro. Since we have had considerable 
success with the intra-molecular plasmid based in vivo recombination system, discussed in Chapter 
2, we also used this substrate in vitro. To increase the sensitivity of this assay, recombination was 
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tested by transforming our in vitro reactions into E. coli and selecting for the desired recombinant 
molecules.  
Assayed by gel electrophoresis, the conditions described in section 2.2.6 yielded 
recombinant products from intra-molecular recombination of the plasmid with pBL90 and pBL224 
(Figure 12). In this gel, as the concentration of Int increases, there is a decrease of supercoiled 
plasmid, accompanied with an appearance of two product bands. Samples of the product were 
transformed into Neb5α cells to test for the loss of the ccdB marker, which will allow transformed 
cells to grow and signifies successful recombination. The results of this experiment are shown in 






Figure 12: In vitro recombination using plasmid substrates 
pBL90 (top) and pBL224 (bottom) were used as substrates for in vitro recombination under 
conditions described in section 2.2.6. Recombination products were digested with proteinase K 
and SDS and run on 0.6% agarose gel, either uncut, or linearized by restriction digestion. The sizes 











Table 2. In vitro recombination frequencies using pBL90 
 Int Concentration 
 0 0.61 nM 2.4 nM 9.8 nM 39.1 nM 156.3 nM 625 nM 
Colonies 
Recovered 
2 2 3 7 48 206 131 
 
An interesting observation from these reactions is that though there are bands 
corresponding to the proper size for recombination products, additional bands of similar size are 
also observed, resulting in double bands for each product. The parental plasmid was linearized 
with NotI, and this restriction site is present in only one of the products, resulting in a linear 4517 
bp product and a circular 2282 bp product that may be supercoiled. Alternatively, these DNAs may 
result from some aberrant recombination, yielding non-standard products. Thus, these additional 
bands and any implications they have will require further study in an optimized system.  
Although successful in vitro recombination was achieved on a few occasions, 
reproducibility and optimization have proven difficult. Preliminary assays showed that Int is most 
active at 37°C and 42°C in vitro. Shortly after these preliminary experiments, in vitro 
recombination reactions ceased to function. Several batches of Int were expressed and purified as 
well as many preparations of plasmid DNA, linear oligos, and various combinations of attB and 
attP sequences were attempted, to no avail. The source of the DNA substrates, however, appear to 
be important. Many different preparations were made using either mini-prep kits (ThermoFisher) 
or phenol-chloroform extraction (Ausubel et al., 1996). Phenol-extracted plasmid preparations in 
general worked poorly relative to mini-prepped plasmid DNA.  
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Although an optimized in vitro system could not be developed, several important pieces of 
information can be gleaned from the successful reactions. First, it appears that Int only converts 
supercoiled plasmid DNA into products, suggesting that there is a requirement for supercoiled 
DNA. However, it is possible that only supercoiled plasmid orients the two attachment sites in 
close proximity to form a synaptic complex, and integration in a phage-host scenario would have 
no such issues. Second, these reactions do not require a cofactor, such as mIHF, as these reactions 
only include Int and DNA. However, this does not preclude the possibility that a cofactor may 
stimulate the reaction in vivo. We note that in vivo recombination in Brujita occurs at significantly 
lower rates than in Lambda Int or L5 Int under normal conditions (Broussard et al., 2013), 
suggesting that there is an inherently lower efficiency with Brujita Int than the other integrases.  
We note that recombination occurs more efficiently in vitro using attB x attB (pBL224) 
than attB x attP (pBL90) substrates (Figure 12). This is unexpected, as the opposite trend was 
observed in vivo (Figure 9E).  
2.4 DISCUSSION 
We have shown that Brujita Int uses an attB site of approximately 24 bp, similar to the 
requirements for L5 Int and Lambda Int (Mizuuchi & Mizuuchi, 1980, Pena et al., 1996). However, 
we demonstrated that the attP sequence is unusual, in that it only requires 49 bp of DNA, much 
less than the 240 bp requirement for Lambda Int and L5 Int (Pena et al., 1997b, Mizuuchi & 
Mizuuchi, 1980). Brujita does not use arm-type interactions and we provide evidence that 
directionality is instead controlled by manipulating protein expression and stability (Broussard et 
al., 2013). Additionally, attB has the same DNA sequence as attL and attP is the same as attR, 
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meaning that there is no method of directionality control and that integration and excision are 
identical events at the molecular level.  
Brujita Int is promiscuous in its ability to recombine with any combination of attachment 
sites and has little (if any) preference between DNA sites. This is especially surprising, considering 
that attP and attB are different sequences and have different length requirements. This raises the 
question as to why this system uses two non-identical sites (attP and attB), when recombination 
can occur in a simpler manner using identical sites, presumably easier to maintain. It appears that 
maintaining the two different sites confers some selective advantage that we are not aware of, such 
as the ability to modulate activity.  
We have also presented evidence that Brujita Int cleaves DNA to create 6 bp overhangs. 
This spacing is uncommon for tyrosine integrases, which generally create 7 bp overhangs (Groth 
& Calos, 2004b, Pena et al., 1996), but typical for recombinases (Cre and XerC/D create 6 bp 
spacers) (Shaikh & Sadowski, 1997, Blake et al., 1997). It is not clear whether the space between 
cleavage points has important implications for other aspects of recombination. 
The in vitro reactions shown here verify that Brujita Int mediated site-specific 
recombination occurs, though at very low efficiency. This agrees with previous data that Brujita 
Int is 10,000-fold less effective in vivo than its L5 Int counterpart, and even 100-fold less efficient 
than L5 Int when stabilized in vivo (Broussard et al., 2013). Thus, it appears that the degradation 
tag is not the only reason for lower levels of recombination in Brujita, but that the protein itself is 
biochemically less efficient than other systems described. With this in mind, our in vitro results 
may represent optimal activity for this protein. The ability to achieve in vitro recombination, even 
inefficiently, shows that there are no essential cofactor requirements such as mIHF. Additionally, 
recombination appears to work better in vitro using attB x attB (pBL224) substrates than attB x 
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attP (pBL90) substrates. It is not understood why this is the case, when in vivo recombination 
shows the opposite trend. Further experiments are needed to answer this question.  
In conclusion, Brujita Int contains several features of the simple tyrosine recombinases, 
while the only features it seems to contain from the integrases is the ability to recombine between 
dissimilar phage and host DNA sites. The control of directionality also proceeds through a novel 
mechanism. This system, therefore, represents a simple tyrosine recombinase masquerading as an 




3.0  REQUIREMENTS FOR BRUJITA INT-DNA BINDING 
Work discussed in this chapter was published in the following article: 
 Lunt, B.L., and Hatfull, G.F., January 2016. Brujita Integrase: A Simple, Arm-
Less, Directionless, and Promiscuous Tyrosine Integrase System. J Mol Biol, Volume 428, Issue 
11, Pages 2289-2306. 
The experiments discussed below were performed by the author. Figures 13-15, 17-21, and 
23-25 were adapted from Lunt and Hatfull, 2016 and were made in collaboration with Graham 
Hatfull. 
3.1 INTRODUCTION 
The DNA requirements for Brujita recombination in vivo reveal that Brujita Int requires small 
DNA sites: attB and attP are ~24 and ~49 bp respectively. However, how Brujita Int binds DNA 
to form the synaptic complex is unknown. This chapter will discuss the experiments performed 
and the data that examines how Brujita Int binds DNA as well as the nucleotides required for these 
interactions.  
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3.2 MATERIALS AND METHODS 
3.2.1 Annealing of Oligos 
Oligos were prepared for binding assays by resuspension to 100 µM in TE. 10 µl of each single 
stranded oligo were combined and incubated at 95°C for 5 minutes, then cooled gradually to room 
temperature. Oligos were then radiolabeled as described below. 
3.2.2 Electrophoretic Mobility-Shift Assays 
EMSAs were performed by established protocols (Ausubel et al., 1996, Villanueva et al., 2015). 
DNA oligonucleotides were 5’ radiolabeled with g-32P ATP and T4 polynucleotide kinase (Roche). 
Non-oligo DNAs (attP292 and attB345) were PCR amplified and gel purified prior to 
radiolabelling as above. Binding reactions were prepared by adding 5 ng radiolabeled probe, 1 µg 
calf-thymus DNA, binding buffer (20 mM Tris pH 8.0, 10 mM EDTA, 25 mM NaCl, 10 mM 
Spermidine, 1 mM DTT) and 1 µl of varying concentrations of Int in a final volume of 10 µl. After 
30 minutes incubation at room temperature, the binding reactions were run on a 5% native TBE 
polyacrylamide gel at 250 V for 2-3 hours. Detection was performed using autoradiography and 
phosphorimaging. 
3.2.3 Competition with Unradiolabeled DNA 
Radiolabeling and binding reactions were performed as above with 125 nM Int and 5 ng 
radiolabeled DNA incubated for 30 minutes at room temperature. Following incubation, 
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unradiolabeled attB was added in increasing concentrations to binding reactions containing 
radiolabeled attP and incubated again for 30 minutes at room temperature. Samples were run on 
5% native polyacrylamide gels for 2 hours at 250 V and imaged as before. The same procedure 
was used with radiolabeled attB and unradiolabeled attP oligos.  
3.2.4 Generation of DNA Spacing Mutants 
attP spacer mutants described in this chapter were generated using site-directed mutagenesis with 
pBL90 as a template. Mutant plasmids were Sanger-sequenced for verification. Plasmids were 
transformed into Int-expressing Stellar E. coli cells and transformed colonies were recovered as 
described in Chapter 2.  
3.2.5 Binding Assays for Ferguson Plots 
Native Tris acrylamide gels were prepared in 7.5, 10, 12.5, and 15% concentrations (29:1 
acrylamide:bisacrylamide) for Trials 1 and 2. Trial 3 used gels of 10, 12.5, 15, and 20% low cross-
linking acrylamide (100:1 acrylamide:bisacrylamide). Binding assays were prepared as described 
above and in (Lunt & Hatfull, 2016). Briefly, 5 ng attB44 DNA (18 nM final concentration) was 
added to binding buffer with or without calf-thymus DNA and incubated with 0, 39, or 156 nM Int 
for 30 minutes. The mixtures were run on each gel until the loading dye band migrated to the end 
of the gel (4-5 hours at 250 V). The gels were fixed and silver stained using a Silver Stain Plus kit 
(BioRad).  
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3.2.6 Ferguson Plots 
Gels were imaged and distances of migrating complexes and standards were measured using 
ImageJ (Schneider et al., 2012, Abràmoff et al., 2004, Rasband, 1997). Relative mobilities and 
standard curves were calculated and plotted according to established protocols (Ausubel et al., 
1996). 
 




pBL90 pBL50 with ccdB (from pDONRZeo) cloned into 
DraI site 
Lunt and Hatfull, 2016 
pBL258 pBL90 with SDM 5’AG-TC in B’ Lunt and Hatfull, 2016 
pBL259 pBL90 with SDM 5’AG-TC in B (reverse 
complement) 
Lunt and Hatfull, 2016 
pBL260 pBL90 with SDM 5’AG-TC in P’ Lunt and Hatfull, 2016 
pBL261 pBL90 with SDM 5’AG-TC in P (reverse 
complement) 
Lunt and Hatfull, 2016 
pBL262 pBL90 with SDM 5’AG-TC in P1 Lunt and Hatfull, 2016 
 
3.3 RESULTS 
3.3.1 Binding of Brujita Int to attB and attP DNA 
To identify the DNA sequence specificity of Brujita integration, we first needed to develop DNA 
binding assays. We resorted to using Electrophoretic Mobility Shift Assays (EMSAs), where 
increasing concentrations of Int are incubated with radiolabeled attP or attB DNA. Binding events 
are observed as a shift to form a slower migrating band, representing a DNA-protein complex.   
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Untagged Brujita IntLong and IntShort were expressed and purified using a nickel affinity 
column, as Int is capable of binding to this resin in its native form. Binding reactions were prepared 
using 292 bp attP, or 345 bp attB PCR amplified and purified sequences. These sequences contain 
the core DNA positioned in the center. We found that binding occurs similarly in both proteins 
with both attP and attB (Figure 13). Binding affinity however, is reduced slightly in IntShort 




Figure 13: Binding of Brujita Int to attP and attB DNA substrates 
A. Binding of Brujita Int to attP DNA. The positions of the origin (O), free DNA (attP), and 
complexes (cmplx1, cmplx2) are indicated. Int concentrations are, from left to right, 0, 0.15, 0.61, 
2.4, 9.8, 39, 156, and 625 nM. B. Binding of Brujita Int to attB DNA. The positions of free DNA 
(attB) and complexes (cmplx1, cmplx2, and cmplx3) are indicated. Int concentrations are the same 
as in A. 
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3.3.2 Competition with Unradiolabeled DNA  
We questioned whether the Int-DNA binding reaction is transient – in which Int binds and releases 
DNA rapidly – or a more permanent interaction. To answer this question, we performed 
competition experiments, where radiolabeled DNA is pre-bound to Int, non-radiolabeled DNA is 
added in increasing concentrations for 30 minutes, and the mixture is run on a gel. We observe 
that when radiolabeled attB is competed with cold attP, the concentration of attP required to 
displace half of the Int is 14 nM, similar to the Kd of the binding reaction (see Figure 14). Likewise, 
25 nM cold attB is required to compete off half of the radiolabeled attP probe. This data suggests 
that the binding reaction is not permanent, as it appears Int is able to release and bind probe to 
equilibrium within the 30-minute timeframe of this experiment. 
 
 
Figure 14: Competition experiments between hot and cold DNA 
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A. Competition experiments between 32P radiolabeled attB and cold attP with detection of 
radiolabeled probe by phosphorimaging. Concentrations of cold attP are, from left to right: 0, 0, 
0, 5, 9, 18, 36, 73, 145, and 290 nM. Int concentration is 53 nM and hot and cold attB are 18 nM. 
B. Competition experiments between radiolabeled attP and cold attB. Concentrations of cold attB 
are, from left to right: 0, 0, 0, 7, 14, 28, 55, 110, 220, and 440 nM. Int concentration is 53 nM and 
hot and cold attP are 9 nM. 
 
 
3.3.3 Int-DNA Stoichiometries 
When free in solution, size exclusion analysis shows that Brujita Int elutes at a size consistent with 
monomeric protein (data not shown). The complexes observed in binding assays could consist of 
DNA bound by either monomers or dimers of Int to multiple sites. To identify the molecular nature 
of complex-1 (fastest migrating) and complex-2 (next fastest migrating) in the binding assays, we 
bound attP and attB DNA with native Int, MBP-tagged Int, and a mixture of both proteins (Figure 
15A-B). If there is more than one binding site on each DNA, we expect to see a hybrid band formed 
when the two proteins are mixed. Indeed, such a hybrid is seen with both attP and attB DNA 
(Figure 15A-B). A faint band of the same size is also found in the MBP-Int alone sample, due to 
the tendency of MBP-fusion proteins to self-cleave (Feher et al., 2004, Arnau et al., 2006). 
However, attP appears to only form a single hybrid, indicating that it contains only two binding 
sites, yet attB shows two or more hybrid bands. The nature of the slower migrating hybrid formed 
with attB is unknown, but it is clear that attB also contains at least two Int binding sites. Therefore, 
these data suggest that complex-1 in each DNA consists of a monomer of Int bound to the input 
DNA and complex-2 represents a second Int monomer occupying an additional site.  
Additionally, because Int can recombine using two attB or two attP sequences, it is possible 
that recombination is occurring in these assays. However, these products would be identical to 
reactants and would therefore be unidentifiable. To address this, we performed binding 
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experiments using different sized DNAs. We observed that there are no hybrids formed when attP 
sequences of varying sizes are mixed, suggesting that only a single DNA fragment is present in 
each band. However, when attB DNA is used, a single hybrid is formed, larger than any other 
complex observed. The nature of this complex is not known, nor why this hybrid runs slower than 
any other complex. It is possible that attB complex-3 represents two molecules of DNA – each 
with two Int proteins bound – involved in interactions resembling a synaptic complex, but this 
does not explain the apparent size of the observed hybrid. We do not observe the formation of 
recombination products with either attP or attB under these conditions.  
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Figure 15: Hybridization assays 
A. Binding of Int and MBP–Int (156 nM and 137 nM, respectively) separately and in combination 
(as indicated) to 32P radiolabeled attP DNA. The positions of complexes and hybrid complexes 
containing both types of Int are indicated. B. Binding of Int and MBP–Int (156 nM and 137 nM, 
respectively) separately and in combination (as indicated) to radiolabeled attB DNA. The positions 
of complexes and hybrid complexes containing both types of Int are indicated. C. Binding of Int 
to two differently sized attP DNA substrates (89 bp and 292 bp, attP89 and attP292, respectively; 
as indicated), separately, and in combination. D. Binding of Int to two differently sized attB DNA 
substrates (44 bp and 345 bp; attB44 and attB345, respectively; as indicated). The nature of the 
lowest migrating complex with both DNAs (marked-?) is unclear. 
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3.3.4 Estimating Sizes of Int-DNA Complexes 
The Int-DNA binding assays described herein have been helpful in elucidating the nature of Int-
DNA interactions. However, the question remains of what the molecular components of each band 
are. The hybridization assays demonstrate that complex-1 is comprised of a DNA molecule bound 
by one Int protein and complex-2 contains a second Int protein bound at a second site. However, 
the nature of complex-3 remains unclear. Complex-3 may comprise two DNAs bound with Int 
proteins, or alternatively may contain up to four Int proteins in a structure resembling a synaptic 
complex. Although these two possibilities predict different molecular weights for the complex, the 
non-denaturing gels used for the binding assays are not directly useful for measuring molecular 
weights. 
To distinguish between these possibilities, DNA binding assays were combined with 
Ferguson plots, where unknown DNA-protein complexes are run on varying concentrations of 
native poly-acrylamide and the relative mobilities of the complexes are compared to standard 
proteins (Ausubel et al., 1996). Under these conditions, larger proteins are more strongly affected 
by gel concentration. By generating standard curves, the actual molecular weights of unknown 
complexes can be estimated.  
The Ferguson plots are shown in Figure 16 and a summary of the calculated and actual 
sizes of the proteins is shown in Table 4. Unfortunately, some complexes were inconsistently 
visible in the four gels and mobilities could not be calculated for all complexes in each experiment. 
Calculated complex sizes are most accurate from ~20-150 kDa, which includes complexes-1 and 
2, but not complex-3. The precision of these measurements was poor, resulting in two of the three 
experiments generally yielding reasonable values, with a third containing an outlier for each 
complex. Oddly, these outliers are scattered through all three experiments, such that there is no 
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one data set that is superior to the others. Trial three seems to provide the best fit for the native 
standards, yet the calculated Int-DNA complex sizes contain a large percentage of outliers from 





Figure 16: Mobilities of protein standards and Int complexes 
A. Representative plots of the -logRf values, from left to right: BSA, Carbonic Anhydrase, and 
Brujita Integrase-DNA complexes. The BSA plot shows relative mobilities of the monomer 
(diamonds) and two isoforms of a dimer (squares and triangles). The two complexes with parallel 
slopes are the same size, but have different mobilities due to charge isomerization, while those 
with different slopes are different sizes. The Carbonic Anhydrase plot shows three charge isomers 
with the same mass and slope. B. Standard curves are attained by plotting the -logKr (slopes of the 
lines in A) against the log molecular weight of known standards. Unknowns can be calculated 





Table 4. Calculated sizes of native protein complexes 
Top. Three trials were run using the listed standards. Actual sizes and calculated sizes based on 
the standard curve are shown. Bottom.  Known complex sizes are shown in black in the Actual 
Size column, with estimates, based on the proposed complex shown in blue. Red signifies 
calculated values that are outliers. Complexes-1, -2, and -3 for each experiment are indicated by 
“c1”, “c2”, and “c3”. 
 
 
It is clear from previous experiments that complex-1 consists of an Int monomer bound to 
a single DNA molecule, while complex-2 contains two monomers bound to a single DNA. Thus 
we can use these complexes to validate the molecular weight standard curves. Two of our trials (1 
 DNAs Ints Actual Size Trial 1 Trial 2 Trial 3 
α-Lactalbumin   14.2 18.7   
Ovalbumin   45 45.2 36.8 44.4 
Carbonic Anhydrase 
Isoform 1 
  29 25.4 27.6 18.0 
Carbonic Anhydrase 
Isoform 2 
  29 19.6 27.2 36.3 
Carbonic Anhydrase 
Isoform 3 
  29 23.1 26.1 35.9 
BSA Monomer   66 101.0 75.5 70.2 
BSA Dimer   132 187.6 219.6 113.6 
Urease Trimer   272 198.8 299.1  
Urease Hexamer   545 175.8 379.2 555.6 
       
Int-attB37c1 1 1 58.8   65.7 
Int-attB37c2 1 2 94.9   85.8 
 
Int-attB37c3 
2 2 117.6    
81.0 2 3 153.7   
2 4 189.8   
Int-attB44c1 1 1 63.2 74.0 62.1 20.8 
Int-attB44c2 1 2 99.3 169.8 105.6 111.2 
 
Int-attB44c3 
2 2 126.4 341.9 319.1  
41.8 2 3 162.5   
2 4 198.6   
MBPInt-attB44c1 1 1 106.7   100.2 
MBPInt-attB44c2 1 2 186.3   194.2 
 
MBPInt-attB44c3 
2 2 213.4    
1478.8 2 3 293   
2 4 372.6   
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and 2) show a similar trend of complex-3 consisting of 2-3 times the mass of complex-2. However, 
the calculated mass for complex-3 is much larger than we would expect if this complex does indeed 
consist of four Int monomers and two DNA molecules. Unfortunately, the data does not appear to 
be consistent enough to make any reliable conclusions regarding this complex.  
3.3.5 Requirements for Int-attB Binding 
To identify the binding sites and DNA requirements for Int-attB binding, we first analyzed deletion 
and substitution derivatives of attB. Binding patterns are shown in Figure 17 and a summary of 
the effects of mutations is shown in Figures 18-19. First, we showed, by deletion analysis, that all 
of the requirements for binding are contained within approximately 37 bp of attB sequence 
(coordinates -14 to +23); when attB37 is truncated by two nucleotides on either side (attB33), 
binding is reduced significantly. Next, we sought to identify the requirements for each binding half 
site. Truncation from the left side show that complex-2 is lost (attB28), but not complex-1 and 
complex-3. Further reduction shows that complex-1 is formed well until attBR3, which consists of 
positions +4 to +27, suggesting that the left boundary of the B’ half site is located in this region. 
Truncation from the right side (attBL1 through attBL9) results in no binding whatsoever, 
suggesting that binding at B is dependent on binding at B’, this is supported by observation that 
the sequences of B and B’ share no recognizable similarity, implying very different affinities for 
each site. Additionally, nearly full-length sequences are required to allow any binding from right-
side truncations (attBL10 through attBL13), confirming that binding is dependent upon B’ 
occupancy, presumably using cooperative interaction between Int subunits. This data suggests that 
the boundary for B’ binding is between coordinates +4 and +21. However, since we cannot isolate 
B half site binding from B’, these boundaries are not clear. It does appear that sequence specificity 
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requirements extend into the first and last 4 bases of attB37, as replacing these nucleotides with 




Figure 17: Int binding to mutant derivatives of attB 
Binding of Int to representative attB DNA substrates. Int concentrations are, from left to right, 0, 
0.15, 0.61, 2.4, 9.8, 39, 156, and 625 nM. See Figure 18 for substrate sequences.  
 
 
We next made a series of transversion mutations in each position in attB to identify specific 
binding site sequences (Figure 19). We first tested binding to B’ using variations of attBR6. 
Substitutions in most positions either do not affect binding, or have little effect. However, 
transversions at positions +9 and +10 eliminate binding entirely (attBR6SDM8 and attBR6SDM9), 
indicating that these two nucleotides are critical for proper Int binding.  
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Figure 18: Summary of Brujita Int binding to attB substrates. 
attB DNA substrates of varying lengths were tested for ability to bind Int. The intensities of 
complexes 1, 2, and 3 (as shown in Figures 15 and 17) are scored from weakest (−) to strongest 
(+++), with the +++ designation corresponding to a similar intensity to input DNA (see Figure 15 
and 17). Overall binding affinities (Kds) are shown, calculated as the Int concentration at which 
50% of the input DNA is bound, regardless of the complexes formed. Base positions in upper case 
black type correspond to wild-type attB sequences, and those in blue lower-case type are non-
native attB sequences corresponding to either plasmid-derived sequences (substrates attB37plas) 
or random sequence. Selected gels are shown in Figure 17. The box encompassing positions +1-



















































































































































Next, we made mutations in the larger attB37 DNA. Binding patterns were similar for those 
positions tested in attBR6. When B half site positions were examined, we found that these 
mutations have no effect on complex-1 formation, as expected, yet several nucleotides reduce 
complex-2 formation when mutated (attB37SDM13 through attB37SDM16). Most prominent 
among these are substitutions at positions -3 and -4 (attB37SDM26 and attB37SDM6), which 
eliminate all binding activity of complexes-2 and 3. This is especially interesting, because these 
two positions make up a 5’-AG dinucleotide, corresponding to the positions found in B’, which 
also form a 5’-AG dinucleotide. The dinucleotides are also symmetrically positioned around the 
cleavage points identified in Chapter 2. While this sequence may be necessary for binding at B, it 
is not sufficient, as this binding does not occur in the absence of B’.  
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Figure 19: Summary of Brujita Int binding to attB substrates with single-base substitutions 
attB substrates with single-base changes from the wild-type sequence were tested for Int binding. 
Complex intensities and affinities are as described for Figure 17. The box encompassing positions 
+1 to +39 indicates the core region.  
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3.3.6 Requirements for Int-attP Binding 
The in vivo site requirements show that attP is longer than attB and that thus binding must differ 
between them. Additionally, the right half sites, B’ and P’ are both located within the core and are 
identical, so the binding requirements for B’ already examined must also apply to P’. Thus any 
differences between the two sequences must be due to the left half of the attachment site. All 
requirements for Int-attP binding are contained within coordinates -42 to +21 (attP63) and some 
of these requirements are located in the extreme 9 bp at the 5’ end of this segment (attP67plasmid, 
attP67NS5, and attP67NS3). Binding occurs differently between attP and attB, as attP37 (which 
includes the same relative positions as attB37) only forms complex-1. This complex presumably 
contains a monomer of Int bound to DNA, as it migrates similarly to attB complex-1. The 
remaining 30 bp (attP30) also result in complex-1 formation. However, the DNA included by 
attP30 does not encompass the P half site, so there must be an additional binding site present. 
Additionally, attP28 – which lacks a full P half site – shows no difference in binding when 
compared to attP37, indicating that binding does not occur at the P half site. Thus attP complex-1 
must be comprised of two different forms, one with Int bound at the P’ half site, and one with it 
bound to the second site, which we name P1. Complex-2 – formed with attP – would then consist 
of two Int subunits bound to attP, one to each site, and each binding independently.  
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Figure 20: Int binding to mutant derivatives of attP 
Binding of Int to representative attP DNA substrates. Int concentrations are, from left to right, 0, 
0.15, 0.61, 2.4, 9.8, 39, 156, and 625 nM. See Figure 21 for substrate sequences.  
 
 
Substitutions in the attP DNA reveal that several positions alter binding to P1 (Figures 20-
21). Positions -32 and -33 are particularly important and substitution of these nucleotides 
eliminates binding entirely. These positions also comprise a 5’-AG dinucleotide, in direct 
orientation to that found in P’ (and B’). When either of these dinucleotides is mutated in a larger 
substrate (attP67), it results in loss of complex-2 and formation of only complex-1 (Figure 23B). 
When the dinucleotide is mutated in both P1 and P’, the resulting DNA has no binding activity, 
indicating that no binding occurs at P. Additionally, this mutation in P does not influence binding. 
Thus it appears that P is not used in this system, a particularly unexpected result, as binding at the 




Figure 21: Summary of Brujita Int binding to mutant attP substrates 
attP DNA substrates of varying lengths or with mutations were tested for ability to bind Int. The 
intensities of complexes 1 and 2 (as shown in Figures 15 and 20) are scored from weakest (−) to 
strongest (+++), with the +++ designation corresponding to a similar intensity to input DNA. 
Overall binding affinities (Kds) are shown, calculated as the Int concentration at which 50% of the 
input DNA is bound, regardless of the complexes formed. Base positions in upper case black type 
correspond to wild-type attP sequences, and those in blue lower case type are non-native attP 
sequences corresponding to either plasmid-derived sequences (substrates attP67plas) or random 








































GAGCGTCGGATAGGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATtcGTCGGGGGTTCGA attP67SDM1 ++ -
GAGCGTCGGATtcGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATAGGTCGGGGGTTCGA attP67SDM2 +++ -






































































GAGCGTCGGATAGGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATAGGTCGGGGGTTCGA attP67 +++ ++ 24
GCGTCGGATAGGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATAGGTCGGGGGTTC attP63 +++ ++ 62
GTCGGATAGGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATAGGTCGGGGGT attP59 ++ - >625
ATAGGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATAGGTCG attP49 + - -
ATAGGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATA attP44 + - -
cgaCcaCcGATAGGTTGCCGAAACCGCCCGTTTTGGTCGTCTGATAATGAATAGGTCGaGacgcgcA attP67NS + - -






































































+1. +10. . . .+20 +30 +40-40. . . .-30 -20 -10
P’P1 Overlap
Figure 8
GAGCGTCGGATAGGTTGCCGAAACCGCCCGTTTTGGTCGTgaGATAATGAATAGGTCGGGGGTTCGA attP67SDM4 +++ ++ 19
attP28TCTGATAATGAATAGGTCGGGGGTTCGA +++ - 34
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3.3.7 Positions of attP Half-Sites and DNA Spacing 
The Brujita attP site consists of two half-sites that exhibit in vitro binding, P1 and P’. There is no 
site with in vitro binding at the traditional P position, though this position is likely to be required 
for recombination. There are two conceivable reasons for this. First, predictive modeling of the 
attP DNA shows that it may have a bend of 22° between the P1 and P half-sites, due to sequence 
alone (Model.it, data not shown) (Munteanu et al., 1998). Additionally, half-sites P1 and P’ are 
positioned approximately 30 bp apart, which is similar to the spacing needed for IHF or HU to 
cause large bends approaching 140° in DNA (Moitoso de Vargas et al., 1989, Bonnefoy & 
Rouviere-Yaniv, 1992). Finally, the P1 half site is oriented in same orientation as P’, opposite to 
the orientation that would be required for the P half site (see Figure 21). Thus it seems possible 
that the P1 site is compensating for the lack of a site at P by using a large DNA bend to position 
the P1 half site in the proper orientation and in proximity to the other binding sites. A second 
possibility is that P1 facilitates binding at P by protein-protein interactions; in which case, a new 
assay would be needed to test this hypothesis. 
In order to test the DNA bending hypothesis, various insertions or substitutions were made 
in the region between P1 and P’ and the effects on recombination were determined (Figure 22). 
There are two A/T rich regions in this portion of attP: a triad of adenines, and a tetrad of thymines. 
Regions rich in A/T nucleotides are often involved in intrinsic DNA bends (Crothers et al., 1990) 
and these nucleotides may be contributing to a bend in this system. To determine whether these 
sequences play a role in this system, they were substituted with C/Gs, which results in a loss of 
recombination ability (Figure 22), indicating that these sequences are important for recombination. 
One, two, five, and eleven base C/G or random nucleotide insertions reduce recombination heavily, 
though it still occurs at low levels (1-4% of wild type). This suggests that the spacing between P1 
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and P’ (or P) is important, as any deviation from this spacing causes a similar defect. If this DNA 
were undergoing a severe bend similar to that caused by HU and IHF, we would expect to see 
eleven base insertions rescue recombination, as this would introduce an additional full turn in the 
DNA and preserve the orientation of the sites on the double helix. Since this is not the case, it is 




Figure 22: Mutations in the proposed bending region 
Substitutions (blue) or insertions (red) were made in the proposed bending region between P1 and 
P. The mutations and the resulting effect on recombination (integration efficiency) are shown as a 









Insertions of two and five bp into the middle of the P half site also reduce recombination 
(3.5 and 0%), which may be due to disruption of the P half site. A single base substitution in the 
adenine triplet (pBL245) does not alter recombination, but a second substitution in the thymine 
tetrad eliminates it, suggesting that the tetrad is important for either binding or recombination. The 
reason for this importance is not clear, as it lies outside of the P half site.  
3.3.8 Half-Site Conserved Dinucleotides 
Mutational analysis of attB and attP binding has revealed an important 5’-AG dinucleotide present 
in each of the five half sites (B, B’, P1, P’, and putative P). In each case, with the exception of P, 
this dinucleotide is critical for Int binding, as mutation of either position is sufficient to abolish 
this interaction. Although binding is not observed at the P half site, it is difficult to conceive a 
method where cleavage could occur without this site. The hypothesis that the DNA was bending 
between P1 and P has no supporting data. Alternatively, we hypothesize that although it is 
undetectable in vitro, binding occurs at P and that this half site is important for recombination. We 
mutated the 5’AG dinucleotide in each of the five half sites and tested their effects on 
recombination (Figure 23A). As expected, recombination is heavily reduced when the dinucleotide 
is mutated in B, B’, P1, and P’. However, alteration of the P half-site dinucleotide results in a 
moderate reduction in recombination, suggesting that this sequence and the P half site are 
important in the recombination reaction. The effect of altering this dinucleotide is less severe than 
with the other half sites, which implies that, though important for recombination, binding at this 
site is not as critical as with the other half sites. Additionally, since binding is undetectable here, 
it is possible that Int is held in position at this site by protein-protein interactions with protein 
bound to the other half sites.  
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Figure 23: Brujita binding at the P half site is required for recombination 
A. attP and attB substrates were mutated in B′, B, P′, P1, or P half sites as indicated (X), changing 
the 5′-AG bases in each half site important for Int binding to 5′-TC. The recombination frequencies 
are shown compared to wild-type (pBL90). B. Int binding to attP substrates with 5′-AG mutations. 
From left to right, wild- type attP, mutations in P′, mutations in P1, mutations in both P′ and P1, 
mutations in P. Concentrations from left to right for attP67 through attP67SDM4; 0, 2.4, 9.8, 39, 




Figure 24: Organization of Brujita attachment sites 
attP and attB share a 39-bp common core sequence (boxed) that overlaps a host tRNAThr gene. Int-
mediated strand exchange occurs within the common core to form attL and attR product sites, and 
mutations analysis suggests stand cleavages at the left end of the common core as indicated by the 
vertical arrows. DNA binding studies show that Int binds to two half sites, B, and B′, in attB and 
to P′ and a leftmost site designated P1 in attP. Int does not bind to the putative P half site in vitro, 
but the site is required for recombination in vivo. Because the recombination requirements do not 
extend beyond the common core to its right, the B′ and P′ sites are identical, and thus, attP and 
attR as well as attB and attL are functionally equivalent. The regions required for in vivo 







In this chapter, we have shown that Brujita Int binds attB DNA to form three complexes and forms 
two with attP DNA. Additionally, IntLong and IntShort bind DNA to form similar complexes and 
both exhibit recombination activity, but IntShort does not bind as strongly, nor recombine as 
efficiently as does IntLong. Thus, it appears that the N-terminal 21 residues of IntLong that are absent 
in IntShort may improve DNA binding and recombination. 
Competitive binding with unradiolabeled DNA reveals that recombinant products or 
synaptic complexes are not formed in these binding reactions. Presumably, this is due to the buffer 
system, as we achieved recombinant products with a different buffer (see section 2.2.6). 
Additionally, from these assays, we learn that these complexes are relatively unstable, as 
unradiolabeled probe is fully capable of competing with pre-bound radiolabeled probe. Thus, the 
DNA-Int binding interactions appear to be short-lived, though the extent of which is unknown. 
This differs from other integration systems, such as Lambda Int, whose synaptic complexes are 
stable for more than 60 minutes (Segall & Nash, 1993). 
The experiments in this chapter also show that Int binds to both attP and attB independently 
as monomers at P1, P’, and B’. We identify the stoichiometries of complex-1 and complex-2: with 
complex-1 containing a monomer of Int bound to a single DNA and complex-2 containing an 
additional monomer bound to the same DNA at a second site. In attP, these binding events are 
independent, but in attB they are cooperative, with binding at B completely relying on occupancy 
of the B’ site.  
The effective range of the Ferguson plots confirms the size and composition of complexes-
1 and 2, but not complex-3. From the data, we confirm not only that the mass of complexes-1 and 
2 conform to the previously demonstrated compositions, but also that Int binds attB DNA in 
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monomeric form, as we see the size of complex-1 consistent with a single monomer and complex-
2 consistent with two monomers. The size of complex-3 may be too large to measure accurately, 
as its mobility is very low in all gels. It is also possible that the data are variable due to a non-
spherical shape of the Int-DNA complexes, which may result in an unusual tumbling radius while 
migrating through the gel matrix. It is unclear, however, whether this would have a significant 
impact on migration. Another potential cause of the high propensity of outliers is poor resolution 
and visualization of the complexes. Three attempts were made to measure these complexes, but in 
each case, staining was poor and some bands could not be easily seen or differentiated. Repeating 
the experiment using longer gels or a better silver staining method may alleviate this problem.  
In this chapter, we identify the Int binding requirements for attB and attP. These binding 
sites agree well with the previously discovered recombination requirements in Chapter 2. 
Approximately 37 bp is required for attB binding and attP requires approximately 60 bp. These 
sequences share a common right side, with identical B’ and P’ half sites, meaning that attL and 
attR are equivalent at the sequence level to attB and attP, respectively. We observe that individual 
nucleotides generally have little effect on binding, with the exception of a conserved 5’-AG 
dinucleotide, found in each half site (B, B’, P1, P, and P’). This dinucleotide is required for binding 
to each half site and recombination is heavily reduced in the absence of a single dinucleotide.  
The lack of binding at P is surprising, especially due to the strong cooperative interactions 
between B and B’. One may expect a similar cooperative interaction to recruit binding at P, but 
this was not observed in any arrangement, even with occupancy of the P’ and P1 half sites. Oddly, 
even though binding is not detectable at P, this dinucleotide is required for in vivo recombination, 
demonstrating that this site is indeed important. It may be that binding at this site is so transient 
and weak that it is undetectable in vitro, or that some cofactor – which facilitates binding – is 
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missing. We prefer the former hypothesis, as in vitro recombination shows that no cofactor is 
required. Interestingly, the P1 half site, which extends to the left in the asymmetrical portion of 
attP, is also required for recombination. Why this site is required is unclear, though it may help to 
stabilize interactions at the P half site. The positioning of this sequence to the left of the core 
binding sites implies that its role in recombination is not catalytic. 
The dissimilarity between the left boundaries of attP and attB may cause site selectivity 
such that recombination with identical sites would be less likely than attP x attB recombination. 
However, we do observe self-recombination (attB x attB and attP x attP, discussed in section 
2.3.6), although at reduced rates compared to attP x attB recombination in vivo. The differences 
between attP x attB recombination and self-recombination may be magnified in vivo with a wild 
type version of Int that does not carry the stabilizing mutation.  
 Insertions between P1 and P show that there is some requirement for proper spacing between 
these sites, and that any deviation nearly eliminates recombination. It is possible that there are 
protein-protein interactions occurring between P1 and P and that this is allowing a monomer to 
bind at the P half site. The insertion experiments support this, as a single base pair insertion would 
rotate the two binding sites approximately 34° (360°/10.5 bp) with respect to each other, 
significantly altering their position and ability to interact. Additionally, substitution of a single 
position of the thymine tetrad eliminates recombination, even though this site is not predicted to 
have a role in binding. Instead, this may be important for allowing DNA to bend slightly, allowing 




Figure 25: A model for Brujita Int-mediated recombination 
Int protomers (blue ovals) bind independently to B′, P, and P′ half sites. Binding at B′ facilitates 
recruitment of an Int protomer to the B half site, presumably through subunit–subunit interactions, 
whereas Int binds independently to P1 and P′ half sites, but not to P. We propose that recruitment 
of Int to the P half site occurs at synapsis, followed by cleavage at the crossover sites (vertical 
arrows), strand exchange, and release of attL and attR products. 
 
  
 We propose a model for Int binding to attachment sites (Figure 25). First, independent 
binding events occur at P1, P’, and B’. Binding at B’ cooperatively recruits Int binding to B. 
Binding at P only occurs at synapsis, with potential interactions from P1, P’, and possibly B to 
stabilize the very weak Int-DNA binding. Cleavage and strand exchange occurs, followed by 
release of the products attL and attR. 
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4.0  STRUCTURAL COMPONENTS OF THE BRUJITA INT SYSTEM 
Work discussed in this chapter is being prepared in the following article: 
 Lunt. B.L., VanDemark, A.P., and Hatfull, G.F., Structure of the 
Mycobacteriophage Brujita Integrase.  
 
The crystal structure data collection and structure determination were performed by Andy 
VanDemark. Many of the figures and tables were made in collaboration with Graham Hatfull and 
Andy VanDemark. 
4.1 INTRODUCTION 
The next step in understanding Brujita Int is to identify how this system forms the synaptic 
complex. This is particularly interesting because of the requirement for the fifth Int binding site at 
P1, as the role for this site is not yet known. We hypothesize that the fifth Int protein is required 
to help recruit a protomer of Int to the weakest interacting core site (P half site, see section 3.4) 
(Lunt & Hatfull, 2016). If true, this would require specific protein-protein interactions that may be 
unique to this system. 
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4.2 MATERIALS AND METHODS 
4.2.1 Expression of Brujita Integrase 
pBL61 was made as described in section 2.2. To generate a catalytically inactive Int (Y269A), 
pBL61 was mutated to create pBL231 using site-directed mutagenesis. 
4.2.2 Protein Expression 
Brujita Int was expressed as in Chapter 2 and (Lunt & Hatfull, 2016). Briefly, plasmids expressing 
Int were transformed into BL21-CodonPlus (DE3)-RIPL cells (Agilent). A single colony was used 
to inoculate a 50 ml overnight culture grown at 37°C in appropriate antibiotics. This culture was 
pelleted and resuspended in 2 L fresh autoinduction media with antibiotics (Studier, 2005). Cells 
were shaken vigorously (160-250 rpm) at 23°C for 18 hours. The cells were pelleted, frozen at -
80°C and resuspended in lysis buffer (10 mM phosphate pH 7.0, 400 mM NaCl, 5 mM imidazole, 
5% glycerol, 1 mM BME). PMSF, leupeptin, aprotinin, and pepstatin were added and cells were 
lysed by 3 passes through a homogenizer. The insoluble protein was pelleted in a Sorvall centrifuge 
at 13,000 rpm, 4°C for 30 minutes and the supernatant recovered. Brujita Int mutants were 
expressed using 1.25 ml overnight starter cultures to inoculate a 50 ml culture. 
4.2.3 Purification of Brujita Int 
The soluble protein was subjected to nickel affinity chromatography, followed by heparin affinity 
chromatography. We have found that like XerC/D, untagged Brujita Int binds avidly to nickel 
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(Subramanya et al., 1997). Following the heparin column, the protein was further purified by size 
exclusion chromatography. The resulting protein was concentrated using a spin concentrator and 
stored at 4°C for future use in 10 mM Tris pH 7.0, 250 mM NaCl, 5% glycerol, and 1 mM BME. 
4.2.4 Crystallization Conditions 
Brujita Int Y269A crystal screens were prepared using the sitting drop vapor diffusion method 
(Stevens, 2000). Initial crystals were observed using a 1:1 mixture of 7 mg/ml protein in 100 mM 
Tris-HCl pH 8.5, 8% PEG-8000. Crystals form very quickly and could be observed within hours. 
Diffraction quality crystals were grown in 100 mM Tris pH 7.5, 5% PEG-3350.  
4.2.5 Seleno-Methionine Crystals 
Protein was prepared as before using established protocols for selenomethionine growth. 
Selenomethionine crystals were grown in 100 mM Tris pH 8-8.5, 4-10% PEG-3350 using 8 mg/ml 
Int. 
4.2.6 Structure Solution 
Brujita Int crystals described here are members of the space group C2, with unit cell dimensions  
a = 133.2 Å, b = 50.1 Å, c = 60.7 Å. Diffraction data from the native Brujita Int crystals were 
collected at the University of Pittsburgh BST3 facility, and selenomethionine crystal data were 
collected at the Advanced Light Source synchrotron. Experimental phasing was performed by the 
single wavelength anomalous dispersion technique using a selenomethionine crystal collected at 
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peak wavelength. The initial model was refined against native data at 1.85 Å using positional 
refinement and anisotropic B-factor refinement. 
4.2.7 Generating Mutants 
Targeted mutants were made by site directed mutagenesis, using pBL61 as a template for 
expression and purification, or pGWB87 as a template for integration assays. Mutants were 
Sanger-sequenced for verification.  
4.2.8 Binding Assays 
Binding assays were performed as described in Chapter 3 and (Lunt & Hatfull, 2016).  
 




pBL90 pBL50 with ccdB (from pDONRZeo) cloned into 
DraI site 
Lunt and Hatfull, 2016 
pBL258 pBL90 with SDM 5’AG-TC in B’ Lunt and Hatfull, 2016 
pBL259 pBL90 with SDM 5’AG-TC in B (reverse 
complement) 
Lunt and Hatfull, 2016 
pBL260 pBL90 with SDM 5’AG-TC in P’ Lunt and Hatfull, 2016 
pBL261 pBL90 with SDM 5’AG-TC in P (reverse 
complement) 
Lunt and Hatfull, 2016 




4.3.1 The Crystal Structure of Brujita Int 
In order to understand how Brujita Int complex formation and synapsis occur, we formed crystals 
and collected X-ray diffraction data from Brujita Int containing the A317E stabilizing mutation, 
as well as Y296A, inactivating the catalytic tyrosine, as this mutant yielded higher quality 
diffraction data. Initial diffraction data was collected at the University of Pittsburgh BST3 facility. 
However, attempts to solve the phage problem using molecular replacement were unsuccessful. 
We instead resorted to using the anomalous dispersion method with selenomethionine crystals. 
These crystals were formed as described in section 4.2.5 and selenomethionine crystal data were 
collected at the Advanced Light Source synchrotron. Details of the structural solution are found in 
section 4.2.6. The structure of Brujita Int has been solved to 1.9 Å resolution. 292 of the 318 amino 
acids are present in the structure, including residues S14 to E305.  
Brujita Int shares a similar structure to the other members of the tyrosine recombinases, 
including XerD and Lambda Int (Aihara et al., 2003, Biswas et al., 2005, Subramanya et al., 1997). 
This is unexpected considering these proteins are distantly related with 18% identity to Lambda 
Int and 26% identity to XerD. The greatest differences in structures occur at the extreme C-
terminus, where there is an increased sequence and structural diversity than in the rest of the 
proteins (Figure 26A, C) (Subramanya et al., 1997).  
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Figure 26: Structural organization of Brujita Int 
A. Brujita Int consists of two domains, a core-DNA binding domain (top) and a catalytic domain 
(bottom), separated by a linker region of ~12 residues. The structure is mostly α-helical, with 
helices labeled A-P, and contains two β-strands arranged in an antiparallel sheet in the C-terminal, 
catalytic domain. Residue numbers indicate the N- and C-termini of the structure. The structures 
of Lambda Int (1Z19_A) and XerD (1A0P) are shown for comparison. Red colored residues denote 
differences from the conserved structure (see also 24D). B. Secondary structure map of Brujita Int. 
The Core-Binding Domain, Linker, and Catalytic Domain are marked by brackets and the variable 
region is underlined. The active site residues R152, H234, R237 and Y269 are boxed and an 
asterisk denotes the position of the catalytic tyrosine, which was mutated to an alanine for 
structural determination. The penultimate alanine residue (A317) was mutated to glutamic acid to 
promote stabilization of the protein. Point mutations were made to test residues important for 
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protein-protein interactions and are shown in red. The full details of these mutants are shown in 
Table 6. C. The Core-Binding Domain, Linker, and Catalytic Domain are marked as in C. 
Secondary structure alignment of Brujita Int, Lambda Int, and XerD showing conservation of 
secondary structure among these proteins. Red regions are deviations from this conserved 
structure. Compare to Figure 26A. 
 
 
Brujita Int consists of two domains joined by a 12-residue linker. It lacks a characteristic 
N-terminal arm-binding domain, which is present in the other tyrosine integrases (Lunt & Hatfull, 
2016, Aihara et al., 2003, Biswas et al., 2005, Pena et al., 1999, Esposito et al., 2001, Broussard 
et al., 2013). The Brujita Int N-terminal, or core-binding (CB) domain, consists of residues 14-111 
and the C-terminal, catalytic domain consists of residues 122-318 (Figure 26A-B). The CB domain 
contains four α-helices (A-D), organized in two perpenticular groups of antiparallel pairs, similar 
to the core DNA binding domain of Lambda Int, Cre, and XerD (Aihara et al., 2003, Biswas et al., 
2005, Guo et al., 1997, Gopaul et al., 1998, Subramanya et al., 1997). Additionally, this domain 
contains a small fifth α-helix (helix-E) just before the linker region, not found in Lambda Int or 
XerD (Aihara et al., 2003, Biswas et al., 2005, Subramanya et al., 1997). The Brujita Int catalytic 
domain contains 11 α-helices (F-P) and two β-strands arranged in an anti-parallel sheet. Also 
present in this domain are the conserved active site residues (R152, H234, and R237), including 
the catalytic tyrosine (Y296) (Figure 26A-B). 
The structure of the CB domain of Brujita Int is particularly similar among all the related 
structures and can be directly superimposed to them, with the exception of Brujita Int helix-E. The 
inter-domain linker is interesting in that it is largely ordered in Brujita Int crystals, despite having 
no organized secondary structure. There is limited electron density found toward the middle of the 
linker, suggesting some flexibility. This long linker is also found in Lambda Int, but not in the 
structures for XerD or Cre, which are also related to Brujita Int (Figure 26A, C) (Ghosh et al., 
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2007, Subramanya et al., 1997, Ghosh et al., 2005). These linkers may be present in all four 
proteins, but it is possible that they are unobserved due to disorder in the crystal structures.  
4.3.2 Domain Rotation 
Though the Brujita CB domain is traditionally considered the DNA binding domain, in vitro 
studies show that protein fragments consisting of this domain (residues 1-114) are unable to bind 
DNA (data not shown). This is supported by the electrostatic analysis of the protein, which in 
Brujita Int and XerD show DNA binding surface in both domains (Subramanya et al., 1997). Thus, 
DNA binding is likely a collaborative action involving both domains.  
A difference between Brujita Int and the structures of Lambda Int and XerD is the 
orientation of the two domains (Subramanya et al., 1997, Aihara et al., 2003, Biswas et al., 2005). 
In Brujita Int, the CB and catalytic domains are oriented approximately 180° relative to Lambda 
Int and XerD, such that a rearrangement would need to occur in order to align them to the latter 
structures. Electrostatic analysis of Brujita Int reveals patches of positively charged residues on 
the lower part of the CB domain, surrounding the linker and on the top of the catalytic domain 
(Figure 27). This is likely the portion of the protein that binds DNA as it is in XerD and Lambda 
Int (Subramanya et al., 1997, Aihara et al., 2003, Biswas et al., 2005). The potential for DNA 
binding is difficult to see in the Brujita Int structure, due to the orientation of the domains (Figure 
27A). Cleavage of Brujita Int in the linker region and subsequent alignment of each domain to 
Lambda Int-DNA (PDB: 1Z19_B) reveals a likely model for how Brujita Int rearranges upon 
contact with DNA (Figure 27B), with the DNA passing through the cavity that is created between 
the two domains and the linker after this rotation. We deduce that active version of Int occupies 
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the same orientation as Lambda Int. The linker region and its flexibility may permit the two 
domains to rotate and rearrange for DNA binding.  
 
 
Figure 27: Brujita Int surface electrostatics  
A. Brujita Int shown in four different angles (90° rotations) show positively charged surfaces (blue) 
around the lower face of the CB domain, the linker region and patches on the top of the catalytic 
domain. It is not obvious how Brujita Int could bind DNA in this arrangement. B. Brujita Int 
domains cleaved and aligned separately to Lambda Int-DNA (1Z19) showing a model for Brujita 
Int-DNA structure. The two views are 90° rotations. Surface electrostatics (left) and cartoon 
models (right) display Int in the same orientations. 
 
 
A structural change is required for XerD to bind DNA. In this case, there must be a large 
conformational change, or separation or the two domains, in order to allow DNA to access the 
active site (Subramanya et al., 1997). Because there is evidence for a conformational change in 
XerD, it is plausible that there is a similar change when Brujita Int binds DNA.  
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4.3.3 Organization of the Active Site 
The catalytic domain of Brujita Int is folded similarly to HP1 Int, XerD, and Lambda Int, (Hickman 
et al., 1997, Subramanya et al., 1997, Biswas et al., 2005), with the exception of Brujita Int helices 
N-P (residues 263-305), comprising the variable region (see Figure 26B-C). This region has 
increased variability in both sequence and structure when compared to related proteins. In the 
Brujita Int structure, these helices (N-P) are organized and folded differently from XerD, HP1 Int, 
and Lambda Int (residues 335-356, Figure 26A, C) (Hickman et al., 1997, Biswas et al., 2005, 
Subramanya et al., 1997, Argos et al., 1986). The variable region includes the catalytic tyrosine 
(A269 in Brujita Int), which must be positioned correctly for attack of the phosphate backbone in 
recombination.   
 The conserved RHR triad coordinates the phosphate backbone to allow attack by the 
catalytic tyrosine (Grindley et al., 2006, Landy, 2015). These residues are oriented to act in 
catalysis, with the three residues found in similar locations in each structure solved (Figure 28A) 
(Aihara et al., 2003, Biswas et al., 2005, Subramanya et al., 1997, Gopaul et al., 1998, Guo et al., 
1997). In Lambda Int, the structure of the catalytic domain without DNA (PDB: 1AE9_A) reveals 
the catalytic tyrosine positioned far (26 Å) from its position when bound to DNA (Figure 28C) 
(PDB: 1Z1G, 1Z1B, 1P7D, and 1Z19). This suggests that the variable region (including the last 
23 residues) in Lambda Int rearranges upon binding to DNA (Aihara et al., 2003, Landy, 2015, 
Kwon et al., 1997). In Brujita Int, the catalytic tyrosine (mutated to alanine in the structure) is 
similarly positioned to that of the Lambda catalytic structure, though the position of the backbone 
in the rest of the variable region is quite dissimilar (Figure 28B). This provides a potential model 
for how the rearrangement can occur in Brujita Int, where – upon DNA binding – the backbone 
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may undergo a simple rotation at the top of helix-M (equivalent to helix-I in Lambda) and 
rearrange the variable region to position the nucleophilic tyrosine for catalysis (Figure 28D). 
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Figure 28: Rearrangement of catalytic tyrosine 
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A. From left to right, the catalytic domain of Brujita Int, the catalytic domain of Lambda Int (PDB: 
1AE9_A), and the catalytic domain of Lambda Int-DNA (PDB: 1Z1G_A). The Brujita Int active 
site residues R152, H234, R237 are shown in blue and the catalytic tyrosine Y269 is shown in red. 
The Brujita Int catalytic tyrosine is positioned away from the rest of the catalytic residues, similarly 
to the structure of Lambda Int, not near the rest of the active site, as it is in Lambda Int-DNA. B. 
From left to right, the variable region of Brujita Int (green), Lambda Int catalytic domain (1AE9_A, 
orange), and merge of both structures. Immediately following Brujita Int helix-M (Lambda Int 
helix αI), the two structures diverge, with Brujita Int forming three helices, N, O, and P in a 
different fold than occurs in Lambda Int. The catalytic residues in both are not positioned to 
perform catalysis. The Brujita Int catalytic residue position is shown in red (Brujita Int A269), and 
Lambda Int in blue (F342 in this structure). C. From left to right, the variable region of Lambda 
Int without DNA (1AE9_A, orange), Lambda Int bound to DNA (1Z1G_A, light blue), and merge 
of both structures, showing the likely DNA-induced conformational shift of the variable region. 
The location of the catalytic residue position is shown in red or blue (Lambda Int F342). D. From 
left to right, the variable region of Brujita Int without DNA, Brujita Int modeled to Lambda Int-
DNA (1Z1G_A), and merge of both structures, showing the potential conformational change that 
may occur upon DNA binding, allowing the catalytic position to be relocated into the active site. 
 
4.3.4 Designing Mutations to Analyze Protein Structure and Function 
As shown in Chapter 3 and explained in section 4.1, Brujita attachment sites contain 5 half sites, 
B, B’, P1, P, and P’, which are all required for recombination. Binding at attB exhibits 
cooperativity with binding at the B site depending on occupancy of B’. Presumably, this 
cooperativity is mediated by protein-protein interactions between subunits of Int (interaction-1 in 
Figure 29). We postulate that the P1 half site is required to mediate binding of Int at the P half site, 
likely through additional protein-protein interactions. Since binding to the P site is unobserved in 
vitro, this interaction may be solely due to cooperative interaction with the P1 bound subunit 
(interaction-3 in Figure 29). Additionally, the Int-DNA complexes must synapse for catalysis and 
strand exchange, which must also form subunit interactions between the members of the active 
tetramer (interaction-2 in Figure 29).  
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Figure 29: Model of Brujita Int binding 
Schematic representation showing Brujita Int binding and formation of synapsis. Brujita Int binds 
independently to sites at B’, P1 and P’. Binding at B’ recruits Int binding at B and these four Int 
protomers recruit another protomer to bind at P, forming a synaptic complex as reported in (Lunt 
& Hatfull, 2016). Proposed subunit interactions are denoted by yellow boxes. 
 
 
These predicted interactions can be examined by assessing DNA binding and 
recombination properties of strategically positioned mutations in Brujita Int. We note that efforts 
to obtain DNA-Int co-crystals have so far been unsuccessful. As a result, potential interactions 
were examined by modeling the Brujita Int structure to a Lambda Int tetramer bound to Holliday 
junction DNA (PDB: 1Z1G). The four subunits are labeled I, II, III, and IV (see Figure 31B). The 
solved crystal structure of Brujita Int contains a single protein in the asymmetric unit and the 
packing arrangement of the subunits reveals many types of different interactions between subunits. 
Three interfaces in particular are large (690, 681, and 1100 Å2) (Figure 30), yet these do not seem 
to correlate with interactions in the modeled tetramer. We designed mutations in locations that 
were predicted to disrupt subunit interaction as well as residues that are conserved in the tyrosine 
recombinases. The DNA binding and recombination properties of these mutants are shown in 
Table 6.  
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Figure 30: Brujita Int crystal subunit interactions 
Three large interfaces were observed in the Brujita Int crystal packing arrangement of (from left 
to right) 690, 681, and 1100 Å2. These do not appear to have any relation to interactions formed 





4.3.5 Effects of Mutations in the Core Binding Domain 
We made a total of 20 Brujita Int mutants with amino-acid substitutions in the CB domain of 
Brujita Int. These mutants were tested for in vivo recombination and DNA binding ability. Thirteen 
of these mutants have strong defects in recombination (<1% of wild-type, see Table 6). Three of 
these are insoluble in vitro, likely due to misfolding (L88D, W94D, N104W/P105W). Three more 
have strong defects in DNA binding (T39W, R43E, and R101E). None of these residues is in a 








Table 6. Binding and recombination properties of Brujita Int mutants 
Mutants were tested for their effect on binding and recombination. Each mutant was tested for its 
ability to bind a 44bp oligo representing attB. The relative binding efficiency is shown with the 
amount of each complex formed relative to control. Strong binding is represented by +++, weak 
binding by +, and no binding by -. The integration efficiency of each mutant protein is shown 
relative to control Int. All proteins contain the A317E stabilizing mutation with the sole exception 
of pBL263 WT (unstable). 
Plasmid Mutation Location Complex attB44 Kd 
(nM) 
Integration  
(% of control)  1 2 3 
pBL61 WT (stable)  ++ +++ + 12 100 
pBL263 WT (unstable)  ++ +++ + 25 0.16 
pBL268 R25A/T28A α-A ++ +++ - 13 54.86 
pBL269 R25E/R27E α-A ++ +++ - 18 0.11 
pBL324 R25A/R27A/ 
T28A/W29A 
α-A ++ +++ - 23 24.3 
pBL341 R27E α-A ++ +++ - 43 48.82 
pBL342 R27A α-A ++ +++ - 32 40.75 
pBL318 A32W α-A ++ +++ - 44 0.0 
pBL319 S36L A-B Loop ++ ++ ++ 89 0.15 
pBL321 T39W α-B + + - >775 0.1 
pBL322 R43E α-B + - - >657 0.3 
pBL340 V63R/E64A α-C ++ +++ - 33 33.68 
pBL272 E72A/N75A α-C ++ +++ + 15 140.26 
pBL323 T80R α-D - - - >442 0.0 
pBL326 L88D α-D    Insoluble 0.1 
pBL327 W94D α-D    Insoluble 0.0 
pBL267 Q96A/Q97A/Q98A α-D ++ +++ - 31 3.12 
pBL328 R101E D-E Loop ++ - - >472 0.0 
pBL329 R101A D-E Loop ++ ++ - 86 0.2 
pBL330 N104W/P105W α-E    Insoluble 0.0 
pBL316 V107A/M108A/I109A α-E +++ + + 45 0.0 
pBL331 I109R α-E ++ + - 304 0.0 
pBL332 P119W/R120E/P121W Linker ++ ++ - 160 0.0 
pBL333 M142H α-G    Insoluble 0.0 
pBL334 G150Y/L151D G-H Loop    Insoluble 0.0 
pBL343 D165A I-1 Loop ++ +++ + 42 32.0 
pBL271 I167A/E168A/R169A I-1 Loop + +++ - 19 87.62 
pBL325 I167E/E168R/R169E I-1 Loop ++ +++ - 30 15.0 
pBL335 M171H/V173R β-1 + ++ - 97 0.0 
pBL336 G175Y/G177Y β-1 ++ +++ + 65 0.0 
pBL315 L183E/P184H β-2 + ++ - 194 0.0 
pBL337 P184W β-2    Insoluble 0.6 
pBL270 V190A/E191A α-J ++ +++ ++ 16 63.56 
pBL317 V190R/E191R α-J ++ +++ + 54 0.34 
pBL338 F203E/P204W J-K Loop    Insoluble 0.0 
pBL320 E279A/I281A/E282A α-O ++ +++ - 24 0.0 
 
 103 
Six of the 20 mutants (R25A/T28A, R25E/R27E, R25A/R27A/T28A/W29A, R27E, R27A, 
and A32W) bind attB similarly to wild type and form complex-1 and complex2, but fail to form 
complex-3 (Figure 31A). This indicates that these mutants can recognize DNA normally and are 
sufficient to mediate interactions between subunits occupying the B and B’ half sites. Though the 
nature of complex-3 is unknown, it may form from interactions which are similar to those needed 
for synaptic complex formation. However, these mutants are not restricted to any single face of 
the protein, and only two are strongly recombination defective (R25E/R27E, A32W, <1% of wild 
type Int) (Table 6). Additionally, mutants such as S36L form complex-3, but are strongly 
recombination defective. Therefore, it appears that though complex-3 may have implications for 
synapsis, this complex is not required for recombination. Helix-A mutants exhibit normal 
recognition of DNA needed for cooperative binding of B and B’ half sites. We propose that helix-
A is important for subunit interactions that form the synaptic complex, specifically, interface-2 
between protomers I and IV (Figure 31B). The mutants R25E/R27E and A32W appear to block 
recombination by either interfering with the interface or preventing domain dynamics, which may 
be needed for strand exchange. Other helix-A mutants may weaken these interactions and thus 
reduce recombination efficiency, but to a lower degree.  
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Figure 31: Brujita Int mutants affecting interface 2 
A. Binding of Brujita Int mutants to a 44 base pair attB substrate (top) and an 89 base pair attP 
substrate (bottom). The positions of free DNA (attB) and complexes (cmplx 1, cmplx 2, cmplx 3) 
are indicated. Int concentrations are from left to right, approximately, 0, 0.15, 0.61, 2.4, 9.8, 39, 
156, and 625 nM. B. Top and side views of a tetramer of Brujita Int modeled to Lambda Int-
Holliday Junction DNA (PDB: 1Z1G). A close up of two core-binding domains (right), showing 
potential interactions involving mutated residues R25, W29, and E72. Other residues shown (R27, 
A32, S36) effect recombination but are not predicted to be involved in protein-protein interactions. 
 
Residues Q96, Q97, and Q98 are located in the C-terminal end of helix-D and are oriented 
in interface-2 (Figure 31B). These substitutions result in protein highly defective at recombination, 
yet binding is nearly unaffected (Table 6 and Figure 32). When this region of Brujita Int is 
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examined in the modeled tetramer, we observe that these residues are positioned within interface-
1 between subunits I and II (Figure 33), though they are also closely positioned to interface-2 
between subunits I and IV (Figure 31B). We also observe that E72 and N75 of subunit I, are 
positioned in close proximity to Q96, Q97, and Q98 in interface-2 and these may play a role in the 
interface. However, the mutant E72A/N75A has no recombination or DNA binding defects.  
Two of the mutations in helix-C (V63R/E64A, E72A/N75A) have only minor defects in 
recombination and successfully bind attB (Table 6). Furthermore, three of the mutants within 
helix-D (T80R, L88D, and W94D) are recombination defective. This is likely due to poor 
solubility (L88D, W94D) or defective binding (T80R), possibly due to defective folding. 
Alternatively, residue T80 may play a role in DNA-recognition, as it is positioned close to the 
region in which DNA is predicted to bind. This portion of helix-D is proposed to contribute to 
DNA binding in XerD (Subramanya et al., 1997, Spiers & Sherratt, 1997). 
We have observed that the Q96A/Q97A/Q98A mutation may interrupt both interface-1 and 
interface-2. However, this mutant appears to bind to attB cooperatively, implying that interface-1 
between subunits I and II is not adversely affected. Thus, the effect on recombination is likely due 
to interference in interface-2. In contrast, mutations in the loop between helix-D and helix-E 
(R101A, R101E) or in helix-E (V107A/M108A/I109A, I109R) exhibit severe recombination 
defects and poor formation of attB complex-2 (Figure 32). These phenotypes suggest that the 
residues contribute to the formation of cooperative interactions between B and B’. The mutant 
V107A/M108A/I109A binds normally to the attP half sites, P1 and P’, as these do not rely on 




Figure 32: Core binding domain mutants affect attB cooperativity 
Binding of Brujita Int mutants to a 44 bp attB substrate. The positions of unbound DNA (attB) and 
complexes (cmplx 1, cmplx 2, cmplx 3) are indicated. Int concentrations are from left to right, 
approximately, 0, 0.15, 0.61, 2.4, 9.8, 39, 156, and 625 nM. 
 
Mutant R101E appears to interfere with the formation of subunit interactions between B 
and B’, as it loses the ability to form attB complex-2. Additionally, it exhibits a reduced capacity 
to form complex-2 with attP DNA, likely due to decreased affinity, as attP binding does not rely 
on cooperative interactions. However, this residue is not positioned to interact with any other 
subunits in our model. Instead, R101 is positioned in the linker between helices-D and E, directed 
toward helix-C (Figure 33). It is possible that this residue stabilizes these helices and that the 
R101E mutant destabilizes them so they can no longer interact with neighboring subunits.  
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Figure 33: Mutants affect formation of interface-1  
Top and side views of a tetramer of Brujita Int modeled to Lambda Int-Holliday Junction DNA 
(PDB: 1Z1G). A close up of two core-binding domains (right), showing potential interactions 
involving mutated residues M108, V63, E64, and Q96, Q97, Q98 on a neighboring molecule of 
Int. V107, E72, N75 also appear to effect protein-protein interactions.  
 
We created an additional mutant in the inter-domain linker (P119W/R120E/P121W). This 
mutant shows a moderate reduction in binding to attB DNA, but a complete loss of recombination 
(Figure 34A). These residues are predicted to be in close proximity to bound DNA and may be 
interfering with DNA-protein contacts. However, it is not clear why this would alter 
recombination. It is possible that this mutant alters flexibility of the linker region needed for 
recombination dynamics.  
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4.3.6 Effects of Mutations in the Catalytic Domain 
An additional thirteen mutations were designed to interrupt subunit interactions in the catalytic 
domain and were tested for integration and binding ability. Of the thirteen mutants, eight cause the 
protein to be strongly defective in recombination (Table 6), four of which are insoluble in vitro 
(M142H, G150Y/L151D, P184W, and F203E/P204W), likely due to protein misfolding. Three 
mutants located in the linker between helix-I and strand β-1 (D165A, I167A/E168A/R169A, and 
I167E/E168R/R169E) and two mutations located in helix-J (V190A/E191A and V190R/E191R) 
are situated at the bottom of the catalytic domain (Figure 34C). Two of these mutants 
(I167E/E168R/R169E and V190R/E191R) have slightly reduced binding affinity, but all bind 
normally to attB, suggesting that they form interaction-2. An intriguing hypothesis is that these 
residues are involved in trans-interactions with the extreme C-terminus of a neighboring subunit, 
much like the trans-interactions formed with the β-7 strand of the Lambda Int tetramer in synapsis 
(PDB: 1Z1G) (Figure 34C-E). One of these mutants (V190R/E191R) has a strong recombination 
defect and one (I167E/E168R/R169E) has a moderate defect, possibly due to interference with this 
trans-interaction. It is also plausible that the rearrangement we propose for positioning the catalytic 
tyrosine also facilitates normal binding, which may explain why these mutants exhibit moderate 
binding defects. The residues I167, E168, and R169 correspond to the region in Lambda that is 
involved in this trans-interaction.  
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Figure 34: Brujita Int mutations affect catalysis 
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A. Binding of Brujita Int mutants to a 44 bp attB substrate. The positions of free DNA (attB) and 
complexes (cmplx 1, cmplx 2, cmplx 3) are indicated. Int concentrations are from left to right, 0, 
0.15, 0.61, 2.4, 9.8, 39, 156, and 625 nM. B. Binding of Brujita Int mutants to an 89 bp attP 
substrate. The positions of free DNA (attP) and complexes (cmplx 1, cmplx 2) are indicated. Int 
concentrations are as in panel A. C. Top, bottom, and right side views of a tetramer of Brujita Int 
modeled to Lambda Int-Holliday junction DNA (PDB: 1Z1G). D. A close up of two catalytic 
domains, showing potential interactions involving mutated residues E279, E168, D165. Additional 
residues (280-305) were not included in the model output. Several residues exhibit interesting 
effects when mutated, but are not clearly involved in subunit interaction, recombination, or binding 
(V190, E191, I167, and R169). E. A close up of two catalytic domains modeled to Lambda Int-HJ 
DNA, (left and middle) showing residues with effects on recombination. The Brujita crystal 
structure (right) showing that these residues are not positioned near the active site. For C-E, active 
site tetrad (RHR) is shown in blue, the nucleophilic tyrosine (Y269) and the variable region are 
shown in orange, and the mutated residues in red.  
 
Three mutations in strands β1 and β2 are of interest. The mutant G175Y/G177Y shows 
slightly reduced binding affinity, but forms all three complexes similarly to wild type in vitro, yet 
cannot facilitate recombination. These residues are not close to the active site – but are near the 
catalytic tyrosine – and their disruption may alter its flexibility or active site formation. 
Additionally, the M171H/V173R and L183E/P184H mutations cause a decrease in binding affinity 
to attB DNA, accompanied by poor in vitro complex-1 formation and a lack of complex-3. The 
L183E/P184H mutation forms complex-2 with attB, suggesting cooperative interactions can occur, 
yet fails to form attP complex-2. This may be a result of defective binding that does not inhibit 
interface formation. It is possible that these mutants are defective due to destabilizing necessary 
interactions within the catalytic domain, particularly those involving the active site. This is likely 
due to the importance of this β sheet region in DNA-binding and catalysis, as is the case in XerD 
(Subramanya et al., 1997). 
The final mutation, E279A/I281A/E282A is located in the variable region at the extreme 
C-terminus, which we propose rearranges upon DNA binding. This region is predicted by the 
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Lambda model to extend to a neighboring protomer, contributing to the catalytic domain of the 
neighbor protein, and may be interacting to form trans-subunit bridges to stabilize the active site.  
4.4 DISCUSSION 
The differences in organization of Brujita attachment sites present questions as to the structural 
differences between Brujita Int and the other characterized tyrosine integrases and recombinases. 
In this chapter, a structural comparison shows that Brujita Int is similar in its fold to XerD and 
Lambda Int, a feature that the larger family of tyrosine recombinases seems to share, even though 
they exhibit limited similarity at the sequence level. The greatest differences between the proteins 
are threefold: the presence of a small helix E in Brujita Int (not found in Lambda Int or XerD), an 
inter-domain linker in Brujita Int and Lambda Int (but not XerD), and a C-terminal variable region, 
which is differs among the three proteins. The variable region is particularly interesting in that it 
contains the nucleophilic tyrosine residue. Additionally, this region of Brujita folds much 
differently than either Lambda Int or XerD, and is not positioned to act in catalysis in the current 
structure.  
Mutational analysis reveals several groups of residues that appear to be important for 
subunit interactions within a model of a Brujita Int tetramer. Additionally, there are many residues 
that effect binding and recombination for reasons not readily identifiable. Some of these mutants 
may destabilize critical interactions, which normally allow proper movement between active and 
inactive forms of Int, or that these mutants interfere with catalytic residues.  
The role of the P1 half-site remains mysterious. As we have previously reported, it is 
required for recombination in vivo using attB x attP sites, though recombination can also occur 
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between attB x attB (Lunt & Hatfull, 2016). Thus it seems that P1 is only necessary in combination 
with P. This is presumably because Int does not readily bind the P half-site, as no binding is 
observed in vitro, and the P1 site may be required to facilitate binding at P (Lunt & Hatfull, 2016). 
The most obvious mechanism would be direct protein-protein interactions between Int bound to 
P1 and P. However, none of the mutants described here necessarily validate this hypothesis.  
The structure of Brujita Int presented here contains two features that must be rearranged in 
order for the protein to act in binding and catalysis. This is an unusual characteristic when 
compared to the other tyrosine recombinases, though many of them have the benefit of DNA in 
their structures. The structure of XerD, which does not contain DNA, similarly requires one of 
these rearrangements (though in a different manner) requiring a separation of the two domains in 
order to bind DNA (Subramanya et al., 1997). Brujita Int likewise necessitates a rotation of the 
two domains approximately 180° in order to create a DNA binding cavity. The C-terminal tail in 
Brujita undergoes a more striking rearrangement, we believe by changing its fold entirely, allowing 
it to position the catalytic tyrosine within the active site, and forming inter-subunit bridges within 
a synaptic tetramer, as has been shown in Lambda Int (Kwon et al., 1997, Aihara et al., 2003, 
Landy, 2015). 
The question of the role of the variable region is intriguing. The variable region has been 
implicated in determining whether tyrosine mediated cleavage occurs in a cis- or trans- 
mechanism. In the case of FLP recombinase, an unusually long variable region may be partially 
responsible for FLP using trans-cleavage (Subramanya et al., 1997, Landy, 1993). Brujita Int 
similarly has a longer than usual variable region, containing ~30 residues that are not present in 
Lambda Int. Considering the large evolutionary distance between the members of the tyrosine 
recombinase family, it is interesting that the most critical residue – the tyrosine nucleophile – is so 
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closely followed by this region that has unusually high variability (Subramanya et al., 1997). This 
variability implies that the region is not under active selection to preserve a function, but mutation 
of these residues reveals that they do play roles in binding and catalysis. Perhaps the variable 
region is used as a method of controlling the activity of the catalytic residue, such as maintaining 
its inactivation until recognition of specific sequences, in order to prevent cleavage of non-specific 
DNA.  
We observe a similar positioning of the C-terminal helices of Brujita Int as has been found 
in Lambda Int catalytic domain (Kwon et al., 1997). In the structures of both these proteins, the 
extreme C-termini are not in position to catalyze recombination. In Lambda Int, this region appears 
to rearrange upon DNA-binding, placing the nucleophile into the proper position in two of the four 
Int proteins involved in the synaptic complex (Aihara et al., 2003). The tyrosines in the remaining 
two proteins are not in position to act in catalysis, and are disordered in the crystal structure 
(Biswas et al., 2005). After initial cleavage and strand exchange, the other two proteins become 
activated and their C-termini rearrange into position for catalysis (Landy, 2015, Grindley et al., 
2006). This C-terminus has been proposed as a mechanism for coordinating the activity of the 
proteins in recombination, ensuring that only the proper subunits are active (Landy, 2015). We 
propose that a similar system functions in Brujita Int and that the protein is held in an inactive 
form until DNA is introduced, whereupon a structural rearrangement occurs, allowing proper 
positioning of the tyrosine nucleophile within the active site. It is also conceivable that this C-
terminus is involved in coordinating the activities of the Int subunits in synapsis. Some of the 
mutants we describe, such as M171H/V173R, G175Y/G177Y, and L183E/P184H may be 
interfering with the ability of the active tyrosine to relocate to its active position.  
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As discussed above, the extreme C-terminus of Brujita Int is likely to change 
conformations to reposition the nucleophile. However, Brujita Int not only contains ~30 additional 
residues in the variable region, but protein levels are controlled through degradation encoded by 
the tag at the C-terminus of the protein (Broussard et al., 2013). Assuming this occurs, how does 
the relocation of the C-terminus into a trans-subunit interaction affect the activity of the 
degradation tag? Additionally, how does this tag affect the assembly of synapsis and 
recombination? These questions may provide further answers into the still unknown differences 
between Brujita Int and canonical tyrosine integrases.  
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5.0  CONCLUSIONS AND FUTURE PERSPECTIVES 
5.1 SUMMARY OF THE BRUJITA INT SYSTEM 
In this work, we have described the Brujita integration system – a model for a new subclass of 
tyrosine integrases – which function and are controlled differently than the canonical systems. 
Though recently discovered, this class has many family members, with 58 currently identified 
among the actinobacteriophages (http://www.phagesdb.org). We have shown here that Brujita Int 
has no N-terminal arm-binding domain and no arm-DNA sites. It also uses an unusually small attP 
site and a normal-sized attB (approximately 60 bp and 37 bp, respectively). Brujita Int does not 
require any cofactors, and is capable of integrative and excisive recombination without the use of 
a recombination directionality factor, such as Xis. This is due to the identity of the right side 
binding sites, P’ and B’, which results in no sequence differences between attP and attR, and attB 
and attL. Thus the integration and excision reactions are the same at the molecular level. This is a 
unique example among the bacteriophage tyrosine integrases, of an integrase not employing an 
RDF for directionality control (Khaleel et al., 2011, Fogg et al., 2014). However, a single mobile 
element recombinase has been reported which uses a similar method of controlling directionality 
by differential expression, though to our knowledge, this system does not use pair expression with 
protein degradation, as Brujita does (Miyazaki & van der Meer, 2013). 
Integrases in the Brujita family contain C-terminal degradation tags, which have been shown 
to increase turnover of the protein, creating a convenient and simple method of controlling 
directionality – not by accessory proteins and DNA topology – but instead by coordinating Int 
expression and degradation (Broussard et al., 2013). This system would respond similarly to that 
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of Lambda Int, where host protease levels regulate stability of the CII protein, which in turn 
regulates the lysogeny decision. In Brujita these factors are combined into Int, which responds to 
host protease levels, governs the lysogeny decision, and performs the recombination reaction 
independently of any other proteins.  
We note that Brujita Int is much less efficient in recombination, both in vivo and in vitro, 
than its counterparts in L5 and Lambda Int (Lee & Hatfull, 1993, Broussard et al., 2013, Nash, 
1975), a feature that may represent an additional level of control in the absence of RDFs. The cause 
of this lower efficiency is unknown, but may be due to the low affinity for the B and P half sites.  
5.1.1 Is Brujita Int an Integrase or Recombinase? 
The lack of directionality control at the protein DNA level, and control of levels of Int 
accumulation present a new method of directionality control for a tyrosine integrase (Broussard & 
Hatfull, 2013, Broussard et al., 2013, Fogg et al., 2014). Without a traditional RDF and no arm-
type interactions, Brujita is essentially a simple tyrosine recombinase, like XerC/D, FLP, and Cre. 
The combination of the C-terminal degradation tag and control of expression allow Brujita Int to 
function like an integrase with directionality control. One question still remains unanswered in this 
area; how is Brujita Int expressed from a lysogen? The best option we can identify is the predicted 
promoter PInt, which occupies the 5’ region of the int coding sequence. The activation of this 
promoter in a Brujita lysogen would produce IntShort, which we have shown is capable of binding 
and recombination, though at lower efficiencies than IntLong.  
Additionally, we have shown that in an integrative plasmid containing Brujita Int is fully 
stable over at least 26 generations, but that the A317E stabilizing mutation is sufficient to 
destabilize it, allowing excision to occur at moderate levels. This supports the idea that Int 
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expression must be induced in the lysogen in order for excision to occur. This hypothesis must be 
further tested, as no activity has yet been shown by this promoter and it is not clear which promoter 
or which conditions stimulate this expression (Emily Shine, personal communication). However, 
a similar system has been employed by Pseudomonas knackmussii integrase IntB13 in the mobile 
element ICEclc (Miyazaki & van der Meer, 2013). In this system, intB13 is expressed 
constitutively for integration, but upon integration, is separated from the promoter Pcirc. Excision 
requires the use of a different promoter, Pint, from which expression occurs at low frequency 
(Miyazaki & van der Meer, 2013). 
 The implications of having two potential versions of Brujita Int – which both have binding 
and recombination activity – are interesting. This may be an artifact, but more likely implies some 
additional level of modulating the recombination reaction. The two versions differ by the N-
terminal 21 residues, which are absent in IntShort. These residues confer some effect on DNA 
binding, as IntLong binds with higher affinity than IntShort. Mutational analyses have shown that 
translation can occur from multiple start sites, so there is likely to be a mixed population of both 
forms in normal phage infection.  
These features represent a fascinating system, one that is neither a true tyrosine integrase, 
nor a simple recombinase. Brujita Int exhibits features of both systems and likely represents an 
evolutionary precursor to more complex tyrosine integration systems, such as Lambda Int 
(Broussard & Hatfull, 2013, Broussard et al., 2013).  
5.1.2 Why is Int Promiscuous? 
We have also shown that Int is capable of promiscuous recombination, or recombination using any 
combination of its sites (attP recombines with attP, and attB with attB, in addition to normal attP 
 118 
x attB recombination). This is an odd feature and to our knowledge is the first tyrosine integrase 
that shows this promiscuity. The lack of site selectivity begs the question that if recombination can 
occur between attB and attB, why has there been selective pressure to develop a more complex 
system, in which two different DNA sites must be maintained?  This conundrum is added to by 
the fact that attP is larger than attB and asymmetrical. For this system to have been maintained, it 
must give the phage some selective advantage over a system involving two identical sites. It is 
possible that there is some level of recognition or directionality control exhibited as a result of the 
difference between the two DNAs. However, because there are no arm-type interactions and no 
RDF, this would have to employ a previously uncharacterized method of control.  
5.1.3 Identification of Interfaces Required for Synapsis 
The Brujita system uses five attachment sites, B and B’ in attB, and P1, P, and P’ in attP. Binding 
occurs independently to P1, P’ and B’. There are strong cooperative interactions between 
protomers at B and B’, such that binding at B only occurs once B’ is occupied. We have shown 
that this cooperativity is likely due to subunit-subunit interactions involving interface-1 and that 
several residues contribute to this interface including residues V107, M108, and I109.  
Another interface must form between subunits on different DNAs, interface-2. We have 
shown that the Q96, Q97, Q98 triad appears to play a role in this interface, along with residues in 
helix-A of the neighboring Int subunit (R25, R27, and W29). Additional residues may be involved 
in interfaces in the catalytic domain, but these are less clear.  
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5.1.4 What is the Role of P1? 
The Brujita attP is unusual in its small and asymmetrical nature. It contains an added binding site, 
P1, to the left of the core sites P and P’. We have demonstrated that P1 and P’ are bound 
independently and that binding does not occur to P in vitro, though this site is required for 
recombination. Unlike other recombination systems, the fifth site, P1, is also required for 
recombination.  
We propose that binding at the P1 site is required for recruitment of Int to the P half site. 
However, Int must also interact with DNA at the P half site to some degree, as the conserved 5’AG 
dinucleotide at P is critical for recombination. It seems probable that an Int subunit-subunit 
interaction allows the synaptic complex to form, followed by cleavage, strand exchange, and 
resolution.  
The P1 and P sites are separated by approximately 12 bp, much more than the separation 
between P and P’, or B and B’, which is predicted to be 1-2 bp by mutational analysis (Figure 24). 
Thus the interaction between P1 and P must be dissimilar to interaction-1 (Figure 29). Predictive 
modeling of the attP DNA suggests that attP has a predisposition to bend between these two half 
sites. Furthermore, mutational analysis reveals that any deviation from the original spacing 
disrupts the interaction between P1 and P. Substitution of a thymine in the tetra-thymine region 
also appears to disrupt the interaction (Figure 22), possibly because this alters the natural bend of 
the DNA. We propose that this region of attP bends naturally and that this bend orients the CB 
domains of two Int subunits in close proximity, allowing the formation of a subunit-subunit 
interaction, possibly similar to interface-1. Alternatively, the proteins may form a new type of 
interface, such as one seen in the crystal contacts (Figure 30). Whichever interface is formed 
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appears to allow the stabilization or recruitment of Int to the P half site – where binding is much 




Figure 35: Model for Brujita Int recombination 
Brujita Int binds to attP at P1 and P’ and attB at B’. Binding at B’ allows cooperative binding of 
Int to B. DNA sequence between P1 and P cause a bend in the DNA, allowing recruitment of Int 
to P, stabilized by subunit-subunit interactions between protomers at B, P1, and P’ in synapsis. 





There are several experiments that may be used to test this model. First, a more thorough 
examination of the DNA in the bending region would clarify if the tetra-thymine region is 
important for bending or binding. If these four residues share the same effect on recombination, 
they are most likely important for bending, as they are positioned outside the P binding site and 
would not affect this interaction (see Figure 22). Additionally, we could confirm that this region 
has a DNA bend with and without Int by using the pBend system and measuring the bend in gello 
(Kim et al., 1989, Zwieb & Adhya, 2009). If this bending is confirmed, FRET analysis could be 
used to verify that the two Int molecules form an interaction between the P1 and P half sites (Gabba 
et al., 2014, Kempe et al., 2016).  
One of the most beneficial methods of clarifying this model would be to form a Brujita Int-
DNA co-crystal. To date, attempts have been made using various sized attB sequences, suicide 
substrates, and engineered binding sites, with no success. Even though binding can be readily 
achieved to the B’ half site, the low affinity of Int for the B site, even with cooperativity, makes 
obtaining a purified complex difficult. It appears that this interaction is too weak to allow Int 
dimerization on the attB site for long periods of time.  
As co-crystallization has remained elusive so far, new strategies will be needed. In order 
to achieve this, modifications may need to be made to Int or the DNA. For instance, using a suicide 
DNA fragment containing a 3-base flap has been instrumental in crystallizing Lambda Int-DNA 
complexes (Aihara et al., 2003). The presence of this flap allows cleavage to occur, creating a 
phosphotyrosine bond. The flap diffuses away, leaving DNA with no phosphate nucleophile to 
liberate the catalytic tyrosine. This method has been tested with Brujita, but additional changes to 
the oligos or binding conditions may be needed to allow cleavage of the DNA. 
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5.1.5 Int-DNA Contacts 
Int-DNA binding appears to be dependent on the 5’AG dinucleotide present in each binding site. 
Though these are not the only positions that affect binding, mutation at any of these positions 
eliminates binding (in the case of B, B’, P1, and P’) and recombination (in the case of P). Thus it 
appears that these nucleotides are directly contacted by Int. Other nucleotides may also have 
protein contacts, but these do not exhibit the severe binding and recombination defects seen with 
this dinucleotide.  
5.2 APPLICATIONS 
The Brujita Int system represents a simple recombination system with directional control 
employed presumably by differential expression of two versions of Int, paired with protein 
degradation. Phage tyrosine integrases have been effective tools for biotechnology for decades 
(Fogg et al., 2014, Groth & Calos, 2004b, Murphy, 2012). However, these are complicated and 
bulky systems that use large DNA sequences and two to three proteins for integration and excision. 
Much simpler options are FLP and Cre, which require no cofactors, but do not have directionality 
control. The Brujita system may be an effective alternative as Int can be expressed within the cell 
for integrating large DNA sequences into bacterial and eukaryotic chromosomes. Brujita Int 
functions well in E. coli and M. smegmatis, and we expect that it will also function in other systems.  
Another use for the Brujita Int system is in synthetic biology, where biological computer 
circuits rely on bi-directional or directional recombinases such as Brujita Int (Bonnet et al., 2012, 
Avlund et al., 2009, Hasty et al., 2002, Fogg et al., 2014). Canonical tyrosine integrases have 
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shown little promise in this field due to their complexity, but the size and simplicity of Brujita Int 
may allow its effective use these circuits (Fogg et al., 2014, Bonnet & Endy, 2013, Meinke et al., 
2016). 
5.3 FUTURE DIRECTIONS 
A complete understanding of the Brujita Int system lacks answers to several questions. First, a 
verification of the method used to express lysogenic form of Int used in excision is needed. 
Secondly, a more detailed understanding of the synaptic complex is required, particularly how Int 
bound to P1 and P interact and the specific protein-protein and DNA-protein contacts that are 
made. Finally, more work is needed to clarify the role of the C-terminal variable region and the 
catalytic rearrangement of Brujita Int. These questions would be greatly aided by additional protein 
and protein-DNA co-crystals.  
This work has laid the foundation for understanding the function of a new subclass of 
tyrosine integrases, integrases of the Brujita Int family. These integrases represent a growing 
population with very different requirements than the canonical Lambda Int system. More work is 
needed to understand the Brujita Int family, yet already these proteins appear to have abundant 
uses as well as information regarding the evolution of the tyrosine recombinases. 
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APPENDIX A 
PHAGE HUNTING WITH MYCOBACTERIUM MINNESOTENSE 
Mycobacterium minnesotense is a recently discovered non-tubercule mycobacterium, found in 
sphagnum peat bogs in Minnesota (Hannigan et al., 2013). It is a non-pathogenic member of the 
same group as the disease causing M. tuberculosis, M. leprae, and M. ulcerans and is a close 
relative of M. arupense, a potential human pathogen (Hannigan et al., 2013). This bacterium is of 
interest to the Hatfull lab, because it is a member of the actinomycetes, which we seek to 
understand from an evolutionary perspective. In particular, we are interested in understanding how 
phages evolve in closely related bacteria, such as between M. smegmatis and M. minnesotense. To 
this end, we sought to develop M. minnesotense as a suitable host for phage hunting. 
We acquired six M. minnesotense isolates as a kind gift from the Dahl lab. These isolates 
are classified as provisional BSL1 bacteria (DSM45633), and have potential for use in phage 
hunting projects as an alternative host. They grow slowly, requiring 5 days growth for liquid 
cultures and 7-10 days for plate cultures. 
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A.1 MATERIALS AND METHODS 
A.1.1 Growth Conditions for M. minnesotense 
M. minnesotense grows best at 30°C and isolates will not grow at 37°C (Hannigan et al., 2013). 
M. minnesotense isolates were found to grow best on 7H11 media supplemented with OADC and 
cycloheximide. Plates were grown at 30°C. Individual colonies appear after 7 days, but are very 
small until 10 days. Colonies begin as a pale yellow, and slowly turn pink to salmon when grown 
in light  
For liquid cultures, isolates grow best in 7H9 supplemented with OADC and 
cycloheximide. Growth in liquid media was performed by shaking vigorously (250 rpm) in baffled 
flasks at 30°C. Cultures reached saturation after 5-7 days.  
A.1.2 Infection Tests Using M. smegmatis Phages 
Phage high-titer lysates were diluted 10-fold to 10-5 in phage buffer. Spot tests were prepared by 
mixing 0.5 ml bacterial culture with 4.5 ml 1 x MBTA and plating on large 7H11 plates 
supplemented with OADC and cycloheximide. The plates were allowed to cool and 3 µl of each 
phage dilution was spotted on the top agar. The plates were incubated for 5-7 days before plaques 
began to appear. 
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A.1.3 Phage Plating 
Soil or peat moss samples were added to 20 ml phage buffer with CaCl2 and shaken vigorously for 
one hour. The samples were pelleted and the phage buffer was filter sterilized. Following 
sterilization, 3.5 ml of this phage buffer was added to 50 ml 7H9 with OADC, 10 µg/ml 
cycloheximide, 3 ml CaCl2, and 500 µl M. minnesotense and shaken at 250 rpm, 30°C for 4-6 days. 
Enrichments were pelleted, filtered, and 50 µl of enrichment was added to 0.5 ml bacteria, mixed 
with 4.5 ml MBTA, and plated on 7H11 plates with OADC and cycloheximide.  
A.2 RESULTS 
A.2.1 Phage Hunting 
M. minnesotense grows on 7H11 media and will not grow in the absence of albumin (Hannigan et 
al., 2013). M. minnesotense bacteria are naturally non-clumpy and do not need to be grown in the 
presence of tween, although tween does not appear to inhibit growth. Plated colonies appear after 
7 days, but are very small until ~10 days. Liquid cultures require 5 days to reach saturation and 
must be grown in baffled flasks with vigorous shaking. Little to no growth is observed without 
shaking or with shaking in non-baffled flasks.  
Since these isolates were found in sphagnum peat bogs, soil and samples were used from 
commercially available sphagnum peat moss from two sources. Several soil samples and 
commercially available peat moss were used in enrichment cultures with each of the six isolates. 
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Many rounds of enrichment yielded a few plates that appeared to have very tiny pinprick plaques, 
however, these could not be isolated for reinfection.  
A.2.2 Infection Using M. smegmatis Phages 
Another question of interest to us is whether M. smegmatis phages are able to cross-infect M. 
minnesotense isolates, since these two bacteria are related. We selected, purified, and made high 
titer lysates of fifteen phages. These lysates were diluted and spotted on M. smegmatis and each of 
the six M. minnesotense isolates. Results are summarized in Table 7 and representative plates are 
shown in Figure 36.  
Many of the phages tested show the ability to cause lysis of all of the M. minnesotense 
isolates at high concentrations (>10^8 pfu/ml). As shown in Table A1, phages D29, Bxz2, HelDan, 
Saintus, Alma, Hedgerow, BPs, and Halo are able to cause lysis of all or nearly all isolates. These 
phages are from different clusters, including A2, A3, A8, A9, B2, and G1. However, oddly, even 
closely related phages are incapable of causing this lysis, as is the case with KBG, an A1, Peaches, 
an A4, and Acadian, a B5. KBG results in some clearing, but only in three of the tested isolates 
and very poorly at maximum concentrations. This raises the question of what differences are 
present that allow some more distant or unrelated phages to lyse the same host, while phages that 
are fairly closely related cannot. Similarly, what differences have arisen to allow certain isolates 
to escape lysis, while others are susceptible, considering they are all highly related at the sequence-
level? Some phages, such as T2 and T4, exhibit a resistance to lysis from without (Abedon, 2011, 
Visconti, 1953) and it is possible that some similar mechanism is at work here. 
Interestingly, though lysis is seen in many of the spots, clearing is only observed at high 
phage concentrations and no individual plaques can be seen, suggesting lysis from without or other 
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abortive infection (Abedon, 2011). This is reasonable, especially when it is noted that many phages 
have distinct host preferences (Jacobs-Sera et al., 2012) and considering the evolutionary distance 
between these two species, in which receptors may be sufficiently different to prevent successful 
infection. Other factors that may contribute to this failure to infect include CRISPR, DNA 
restriction, and immunity systems (Jacobs-Sera et al., 2012), though due to the evolutionary 
distance between these bacteria, abortive infection is most likely a result of an incompatibility 
rather than immunity against infection. The clearing observed may be a result of enzymatic activity 
from the phage tails, such as the lysozyme activity of T4 gp5 (Arisaka et al., 2003), or the 
endorhamnosidase activity of the P22 tails-pike (Goldenberg & King, 1982).   
 
 
Figure 36: Lysis of M. minnesotense isolates by mycobacterium phages 
Shown are dilutions of phages plated on M. smegmatis (top) or M. minnesotense (bottom) with 
phages dilutions from concentrated (left) to dilute (right). A summary of lytic ability is shown in 





Table 7. Infection patterns of various M. smegmatis phages. 
Phages from several different clusters were tested for their ability to infect M. minnesotense 
isolates. Lytic ability is scored based on  whether a zone of clearing was observed at high (+), 
medium (++), or low concentration (+++), or no clearing  (-). 
 
  Lytic Ability 
Phage Cluster M. smeg DL47 DL49 DL150B DL184 DL630 DL678A 
KBG A1 +++ - + + - - + 
D29 A2 +++ + ++ ++ + - + 
Bxz2 A3 +++ + ++ ++ + + + 
HelDan A3 +++ + ++ ++ + ++ ++ 
Peaches A4 +++ - - - - - - 
Saintus A8 +++ + + + + + + 
Alma A9 +++ ++ ++ +++ ++ + ++ 
Hedgerow# B2 +++ + ++ ++ + ++ ++ 
Acadian B5 +++ - - - - - - 
Tweety F1 +++ - + - - - - 
BPs G1 +++ + ++ ++ + ++ ++ 
Halo G1 +++ + ++ ++ + ++ ++ 
TM4 K2 +++ + + + + - - 
Faith L2 +++ - - - - - - 













M. minnesotense appears to be sufficiently different from M. smegmatis that phages cannot cross-
infect, though many of the phages tested can cause clearing through abortive infection or lysis 
from without. As a result M. minnesotense would be a prime candidate for studying the evolution 
of related phages, assuming that infecting phages can be isolated. The conditions that were 
attempted were insufficient to find phages for M. minnesotense, but this could be due to lack of 
ideal soil samples (particularly those of the peat bogs from which the bacteria were isolated) or 
proper infection conditions. Particularly, varying levels of CaCl2 or MgCl2 may improve infection, 







BRUJITA INT-DNA CO-CRYSTALLIZATION 
B.1 MATERIALS AND METHODS 
B.1.1 Annealing of Oligos 
Oligos were annealed as described previously in Chapter 3. Briefly, oligos were prepared for 
binding assays by resuspension in approximately 1 ml Annealing Buffer (10 mM Tris pH 7.5, 50 
mM NaCl). Equal molar amounts of each single stranded oligo were combined and diluted 10-fold 
in Annealing Buffer. The oligos were then incubated in a boiling water bath for 5 minutes and 
allowed to cool gradually to room temperature. Oligos were vacuum concentrated and run over a 
size exclusion column, then concentrated in a spin concentrator prior to Int binding trials.  
B.1.2 DNA Binding Reactions 
The Int binding ability of each oligo was tested by mixing increasing concentrations of Int with 1 
µl oligo at near equal molar ratios and buffer was added to a total volume of 10 µl. The mixture 
was incubated at room temperature for 20 minutes and run on a 3% agarose gel. Gels were 




Both Int and DNA oligos were dialyzed into buffer containing either 10 mM Tris pH 7.0, 250 mM 
NaCl, 5% glycerol, and 1 mM BME, or 10 mM Tris pH 7.0, 800 mM NaOAc, 5% glycerol, and 1 
mM BME.  
B.2 RESULTS 
 
To better understand how synapsis and Int-DNA binding occur biochemically, we attempted to 
form Int-DNA co-crystals for X-ray diffraction. Many different preparations of stabilized Int 
(A317E), as well as stabilized, catalytically inactive Int (Y269A/A317E) were tested with a variety 
of oligos. To form Int-DNA crystals, we first needed oligos that form stable complexes with DNA. 
Binding reactions were examined for stability of the complex in gello, beginning with attB35 
derivatives. However, due to the weak binding nature of the B half site, all constructs similar to 
wild type attB failed to form stable complexes. We next examined constructs containing a single 
binding site (attB1/2hairpin, attB1/2.6, and attBR7). These constructs were more promising and 
formed relatively stable complexes. However, large scale preparation of these complexes results 
in rapid precipitation of Int, when mixed with DNA at high concentration. To avoid this, we 
increased the NaCl concentration in the buffer. A concentration of 400 mM-500 mM NaCl 
prevents precipitation, but effectively inhibits DNA-Int binding. We attempted to dialyze the 
complex into lower salt concentrations which would allow a more gradual change, hopefully 
stimulating binding once the salt concentration was low enough. However, Int is not stable below 
 133 
200 mM NaCl, and this pattern held true for the DNA-Int mixture. Thus, stable binding could not 
be achieved with these oligos. 
To achieve a more permanent interaction, we designed suicide oligos, containing a 3-base 
flap, similar to that previously described (Aihara et al., 2003). This oligo is designed so that Int-
mediated cleavage can occur, leaving a small, free tri-nucleotide to diffuse away. The 3-base flap 
then anneals in place of the diffused DNA, but since it lacks a free hydroxyl group, it cannot attack 
the phosphotyrosyl bond between Int and the DNA backbone. This creates a stable covalent 
linkage between Int and DNA, and may help to isolate the complex. Unfortunately, we were unable 
to get significant levels of cleavage in vitro. This may first require the development of an efficient 
in vitro recombination or cleavage reaction, which has been difficult to this point.  
Since binding can be achieved with a single B’ half site, we designed an oligo containing 
two half sites based on the sequence found at B’ (attB40). Both sites should now bind DNA 
efficiently, and they presumably can also participate in cooperative binding, as occurs in wild type 
attB. Indeed, EMSAs using this oligo show increased formation of complex-2, while complex-1 
is relatively reduced, indicating that this oligo participates in better complex-2 formation than our 
previously used DNAs. However, we still observe the rapid precipitation of Int when mixed with 
this oligo at high concentrations. Thermal shift assays revealed that Int is most stable in NaOAc, 
so we adjusted our buffers accordingly, though this did not alter the precipitation of Int when 
mixed with DNA. We resorted to mixing Int and DNA at low concentration in high salt (800 mM 
NaOAc) buffer, then using a spin concentrator (Millipore) to concentrate the mixture while buffer 
exchanging to lower salt (100 mM NaOAc). We observed a large loss in Int using this method, but 
it appeared to give us stable complex, so we proceeded to crystallization trials.  
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Crystallization trials were prepared using a twelve-standard condition screen prepared by 
the VanDemark Lab. Int-attB40 complex at ~7 mg/ml was mixed with each condition in the sitting 
drop vapor diffusion method (Stevens, 2000). After several days, small, micro-, pseudo-crystals 
could be observed in a single well (100 mM Tris pH 8.5, 30% PEG 3350, 200 mM MgCl2). Further 
analysis revealed that these were likely DNA crystals. Crystals were also observed in another 
condition (1 M Na Cacodylate pH 6.5, 50% PEG 8000, 2M NaOAc) with Int A317E. These may 
represent DNA crystals, as they have not been reproduced. Additional screens could not reveal 
any conditions forming promising initial Int-attB40 crystals.  
 
 
Table 8. Oligos for Int-DNA co-crystallization 
Forward and reverse oligo sequences are shown with the predicted binding sites in blue. 





















Though we were unable to find any oligos that allow the formation of stable complexes, we have 
identified some features that would be important in oligos in future trials. First, the suicide 
substrates, though unsuccessful here, have the greatest potential for allowing stable complex 
formation. It is likely that the substrates or buffer conditions we used were not properly designed 
for in vitro cleavage. Future work in developing in vitro cleavage assays would give necessary 
information for the development of these oligos and conditions.  
It appears that the B half site is far too weak to form stable DNA-Int complex, even in 
cooperation with the B’ site. Thus, any oligos using multiple half sites would require an engineered 
B site to improve this binding. The oligo we developed, attB40, appears to be a modest 
improvement, but still does not form lasting stable complex with Int.  
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